MEDICAL RESEARCH FOUNDATION OLD NO.18, NEW NO.41, COLLEGE ROAD, 600 006

ANNUAL REPORT & ACCOUNTS 2019 - 2020 MEDICAL RESEARCH FOUNDATION

To November 27, 2020 The Members of the Medical Research Foundation NOTICE

NOTICE IS HEREBY GIVEN TO THE MEMBERS OF THE MEDICAL RESEARCH FOUNDATION THAT THE 42nd ANNUAL GENERAL MEETING OF THE FOUNDATION WILL BE HELD ON SATURDAY, THE 19th DECEMBER 2020 AT 6.00 P.M. THE MEETING WILL BE HELD ONLINE DUE TO THE PREVAILING COVID PANDEMIC.

AGENDA 1. To consider and adopt the Audited Income and Expenditure Account for the year ended March 31, 2020 and the Balance Sheet as at that date together with the Report of the Auditors thereon. 2. To consider and adopt the Annual report of the Foundation for the year 2019-20 3. To appoint Auditors and to fix their remuneration for the year ending 31st March 2021. 4. To elect Members to the Board of Management in the vacancies caused by the retirement of the following Members, who being eligible offer themselves for re- appointment

Sl. No Name Category Of Membership

1 Mr. Ashok Kumar Mehta Donor member

2 Mr. Mani S Subramonian Patron member

3 Mr. B S Taraporevala Patron member

4 Dr. Girish Shiva Rao Honorary member

Contd…2

1 MEDICAL RESEARCH FOUNDATION

5. To elect Members to the Board of Management in the existing vacancy. 6. To amend clauses of MoA and Bye-laws of Medical Research Foundation as per current laws and financial position

Kindly make it convenient to attend the meeting.

G. RAMACHANDRAN Honorary Secretary & Treasurer Encl: 1. Explanatory statement for Item 4 of the Agenda 2. Audited Accounts for the year ended March 31, 2019

2 MEDICAL RESEARCH FOUNDATION

Explanatory statement for Item 4 of the Agenda

Their term of appointment expires on 29th September 2020. As per 11(v) of the Bye-laws of the Foundation read with Section 15(5) of the Societies Registration Act 1975, they are eligible for reappointment to the Board of Management. They have offered themselves for reappointment.

As per rule no 10(c) of the Memorandum of Association and Bye laws of the Foundation, the 2 directors Mr. B S Taraporevala and Mr. Mani S Subramonian who represent Sir Ratan Tata Trust and M/s Jaslok Hospital and Research Centre respectively are eligible for automatic re- election. In the absence of any specific notice to the Foundation from these two organizations notifying change of their nominees, these 2 members will get elected automatically.

3 MEDICAL RESEARCH FOUNDATION

Explanatory statement for Item 6 of the Agenda To amend clauses of MoA and Bye-laws of Medical Research Foundation stated as below: EXISTING CLAUSE PROPOSED CLAUSE

10 (I) MEMBERSHIP: 10 (I) MEMBERSHIP: 10 (c ) Patron Members: 10 (c )Patron Members: Persons or Firms or Institutions or Corporate Henceforth, Persons or Firms or Institutions or Bodies making a lump sum donation of Rs. 50 Corporate Bodies making a lump sum donation Lakhs or more may be invited to become Patron of Rs. 500 Lakhs or more may be invited to Members. Firms/Institutions/Corporate become Patron Members. This increase will not Bodies, who have become Patron Members, are disqualify any of the current patron members entitled to nominate one representative to Firms/Institutions/Corporate Bodies, who have exercise their rights and privileges of become Patron Members, are entitled to membership by a resolution passed by their nominate one representative to exercise their respective Board. In case the nominated person rights and privileges of membership by a is to be elected to the Board of Management, resolution passed by their respective Board. In the Firms/Institutions/Corporate Bodies shall case the nominated person is to be elected to duly authorize the same person to function as a t h e B o a r d o f M a n a g e m e n t , t h e member of the Management in any capacity. As Firms/Institutions/Corporate Bodies shall duly far as the Patron Member, M/s Jaslok Hospital authorize the same person to function as a and Research Centre, 15 Dr. G. Deshmukh Marg, member of the Management in any capacity. As Mumbai 400 026, is concerned, they are far as the Patron Member, M/s Jaslok Hospital entitled to nominate 2 representatives as their and Research Centre, 15 Dr. G. Deshmukh Marg, nominees to the Board of Management. The Mumbai 400 026, is concerned, they are Patron Members, M/s Keligavan Investment and entitled to nominate 2 representatives as their Trading Private Limited, M/s Jamwadi nominees to the Board of Management. The Investment Trading Private Limited, Sir Ratan Patron Members, M/s John Fowler Ocular Tata Trust and Essel Mining and Industries Lenses Private Limited, M/s Jamwadi Limited, Kolkata are entitled to nominate as Investment Trading Private Limited, Sir Ratan any other Patron Member [with the exception of Tata Trust and Essel Mining and Industries M/s Jaslok Hospital and Research Centre] one Limited, Kolkata are entitled to nominate as representative each as their nominee to the any other Patron Member [with the exception of Board of Management. The nominees of the M/s Jaslok Hospital and Research Centre] one above Patron Members, namely, M/s. Jaslok representative each as their nominee to the Hospital and Research Center, M/s Keligavan Board of Management. The nominees of the Investment and Trading Private Limited, M/s above Patron Members, namely, M/s. Jaslok Jamwadi Investment Trading Private Limited, Hospital and Research Center, M/s John Fowler Sir Ratan Tata Trust and Essel Mining and Ocular Lenses Private Limited , M/s Jamwadi Industries Limited, Kolkata shall be entitled to Investment Trading Private Limited, Sir Ratan be elected as the Members of the Board of Tata Trust and Essel Mining and Industries Management and shall be automatically Limited, Kolkata shall be entitled to be elected entitled to be re-elected upon completion of as the Members of the Board of Management the term unless the said Patron Members desire and shall be automatically entitled to be re- to appoint other nominees in place of the elected upon completion of the term unless the retiring nominees. said Patron Members desire to appoint other nominees in place of the retiring nominees.

4 MEDICAL RESEARCH FOUNDATION

EXISTING CLAUSE PROPOSED CLAUSE

10 (d) Donor Members : 10 (d) Donor Members : Persons or Firms or Institutions or Corporate Henceforth Persons or Firms or Institutions or Bodies making a lump-sum donation of Rs.25 Corporate Bodies making a lump-sum donation Lakhs or more but less than Rs.50 Lakhs may be of Rs.100 Lakhs or more but less than Rs. 500 invited to become DONOR MEMBERS. Firms / Lakhs may be invited to become DONOR Institutions / Corporate Bodies who have MEMBERS. This increase will not disqualify any become DONOR MEMBERS are entitled to of the current Donor members. Firms / nominate one representative to exercise their Institutions / Corporate Bodies who have rights and privileges of membership, by a become DONOR MEMBERS are entitled to resolution duly passed by the Board. In case the nominate one representative to exercise their nominated person is to be elected to the Board rights and privileges of membership, by a of Management, the Firms / Institutions resolution duly passed by the Board. In case the /Corporate Bodies shall duly authorize the nominated person is to be elected to the Board same person to function as a member of the of Management, the Firms /Institutions Board of Management in any capacity. /Corporate Bodies shall duly authorize the same person to function as a member of the 10 (e) Associate Members: Board of Management in any capacity. Persons / Firms/ Institutions / Corporate Bodies contributing a lump sum donation of 10 (e) Associate Members: Rs.1,00,000/-or more but less than Rs To remove Associate member category since it 5,00,000/- shall be eligible to become has lost its relevance ASSOCIATE MEMBERS. (ii) REMOVAL OF MEMBERS: (ii) REMOVAL OF MEMBERS: Any member of the Foundation who is of Any member of the Foundation who is of unsound mind or who is an undischarged unsound mind or who is an undischarged insolvent or has at any time been adjudged as insolvent or has at any time been adjudged as insolvent or has at any time been convicted by a insolvent or has at any time been convicted by a Court of an offence involving moral turpitude, Court of an offence involving moral turpitude, shall be removed from the membership of the shall be removed from the membership of the Foundation by the Board of Management and an Foundation by the Board of Management and an appeal shall lie against such removal to the appeal shall lie against such removal to the General Body of the Foundation and the General Body of the Foundation and the decision of the General Body shall be final. decision of the General Body shall be final. Members who have not attended any two consecutive General Body Meetings (AGM/EGM) shall be removed from the membership of the Foundation by the Board of Management and an appeal shall lie against such removal to the General Body of the Foundation and the decision of the General Body shall be final

5 MEDICAL RESEARCH FOUNDATION

EXISTING CLAUSE PROPOSED CLAUSE

13. THE BOARD OF MANAGEMENT: (hereinafter 13. THE BOARD OF MANAGEMENT: (hereinafter called the 'Board') called the 'Board') ii. “The members constituting the Board shall ii. “The members constituting the Board shall not be more than Thirty Three out of which One not be more than Thirty Three out of which One member shall be from Founder member, eight member shall be from Founder member, eight members shall be from Patron members members shall be from Patron members including patron members described under 10 including patron members described under 10 (c) above, thirteen members shall be Donor (c) above, up to thirteen members shall be members, and eleven members shall be Donor members, and up to eleven members Honorary members. Of these eleven Honorary shall be Honorary members. Of these eleven members, Six members can be elected from Honorary members, Six members can be amongst the Ophthalmic consultants and Senior elected from amongst the Ophthalmic Executives permanently employed by MRF and consultants and Senior Executives permanently scientists permanently employed by Vision employed by MRF and scientists permanently Research Foundation, and the balance five employed by Vision Research Foundation, and Honorary Members not employed by MRF. As far the balance five Honorary Members not as M/s Jaslok Hospital and Research Center is employed by MRF. As far as M/s Jaslok Hospital concerned they are entitled to nominate two and Research Center is concerned they are persons to the Board of Management. The entitled to nominate two persons to the Board persons nominated by M/s Jaslok Hospital and of Management. The persons nominated by M/s Research Center, M/s Keligavan Investment and Jaslok Hospital and Research Center, M/s John Trading (P) Ltd., M/s Jamwadi Investment Fowler Ocular Lenses Private Limited., M/s Trading (P) Ltd, Sir Ratan Tata Trust, Essel Jamwadi Investment Trading (P) Ltd, Sir Ratan Mining and Industries Limited, Kolkata are Tata Trust, Essel Mining and Industries Limited, entitled to be elected as members of the Board Kolkata are entitled to be elected as members of Management as stipulated under clause 10(c) of the Board of Management as stipulated under of the bye laws” clause 10(c) of the bye laws”

16. MEETINGS & RESOLUTIONS: 16. MEETINGS & RESOLUTIONS: I. The President shall preside at the Board I. The President shall preside at the Board Meetings and in his absence the Vice President. Meetings and in his absence the Vice President. In the absence of both, a Chairman shall be In the absence of both, a Chairman shall be elected from among the members present to elected from among the members present in conduct the proceeding of the meetings. person or through any of the available video conferencing to conduct the proceeding of the meetings

6 MEDICAL RESEARCH FOUNDATION

EXISTING CLAUSE PROPOSED CLAUSE

18. GENERAL: 18. GENERAL: The Research Centre Hospital - Sankara The Research Centre Hospital - , of the Medical Research Nethralaya, of the Medical Research Foundation shall provide diagnostic and Foundation shall provide diagnostic and treatment facilities to all without distinction of treatment facilities to all without distinction of caste, creed race, religion or language but also caste, creed race, religion or language but also (a) free to at least 40 per cent of all their out- (a) free to at least 40 per cent of all their out door patients: patients: (b)free to all inpatients belonging to families (b)free to all inpatients belonging to families with less than monthly income of Rupees Three with less than monthly income of Rupees Twelve thousand five hundred or any other income Thousand or any other income limit which may limit which may be decided by the Board from be decided by the Board from time to time, time to time, keeping for this purpose at least keeping for this purpose at least fifteen percent fifteen percent of all the bed reserved for such of all the bed reserved for such patients patients

G. RAMACHANDRAN Honorary Secretary & Treasurer Important Note: Dear Members, We request you to kindly share your email ids & phone numbers for the current and future meetings so that we will be able to send an e-invite/link to the same id as the meeting will be held online due to the prevailing Covid pandemic situation. Kindly send the same to Ms. Akila Ganesan – Director Administration, Medical Research Foundation [email protected] / [email protected] with your name & company’s name at the earliest.

7 MEDICAL RESEARCH FOUNDATION

SANKARA NETHRALAYA

MISSION STATEMENT QUALITY OBJECTIVES

The mission of Sankara Nethralaya is to To maintain the quality of ophthalmic provide Total Eye-care solutions of highest services in accordance with international standards to all sections of community through standards. a team of competent, committed and Effective utilization of infrastructure compassionate professionals in a patient- facilities including manpower. friendly environment. To ensure continued patients' satisfaction. Sankara Nethralaya is also committed to create a CENTRE of Excellence for ophthalmic professionals for continuously updating their Ongoing care and concern for maintaining knowledge through Education, Training, and high level of staff satisfaction and carrying innovative centric Research to motivation. benefit the entire ophthalmic community. In all our undertakings we will be guided by the underlying philosophy of Sankara Nethralaya.

PHILOSOPHY QUALITY POLICY

Let the word Sankara of Sankara Nethralaya We pledge to meet the patients' requirements ever remind me and my associates His Holiness' by offering expert ophthalmic care with command that there be a missionary Spirit in compassion through a committed professional the project. team. Let the word Nethralaya constantly remind me We commit to achieve Continual quality and my colleagues that the place of our work is improvement to our services through the an Alaya. Work will be our Worship which we Quality Management System while complying shall do with sincerity, dedication and utmost with all applicable regulatory requirements. Love

8 MEDICAL RESEARCH FOUNDATION

BOARD OF MANAGEMENT 2019 - 2020

President Dr. Girish S. Rao

Honorary Secretary & Treasurer Mr. G. Ramachandran

Other Members of the Board 1. Dr. Ananthkumar Badrinath Member 2. Mr. Ashok Kumar Mehta Member 3. Dr. Badrinath S.S. Member 4. Mr. Jagdish M. Chanrai Member 5. Mrs. Mallika Srinivasan Member 6. Mr. Mani. S. Subramonian Member 7. Mrs. Nina B.H. Kothari Member 8. Mr. Parekh R.C. Member 9. Ms. Prabhavathy Seethapathy Member 10. Mr. Ramakrishna C. Member 11. Dr. Ramasami T. Member 12. Mr. Rajaratnam S. Member 13. Ms. Rajashree Birla Member 14. Mr. Raju Barwale Member 15. Mr. Sirish R. Barwale Member 16. Mr. Sugalchand Jain N. Member 17. Dr. Surendran T.S. Member 18. Dr. Saravanan M. Member 19. Mr. Taraporevala B.S. Member 20. Dr. Usha Zehr Barwale Member 21. Mr. Vaidyanathan V. Member 22. Dr. Vasan K.S. Member

9 MEDICAL RESEARCH FOUNDATION

President & Medical Director Administration : Dr. Girish Shiva Rao

Managing Director : Dr. K. S Vasan

Director Administration : Ms. Akila Ganesan

Deputy General Manager (Finance) : Ms. Susila Girisan

Auditors : M/s. S. Viswanathan, LLP Chartered Accountants, Chennai

Bankers : HDFC Bank Ltd., State Bank of India

Registered Office : Old No.18, New No.41, College Road, Chennai - 600 006. Locations of Sankara Nethralaya:

Tamil Nadu Andhra Pradesh

Main Hospital Sri Srinivasa Sankara Nethralaya Old No.18, New No.41, College Road, Chennai-600006. Central Hospital, K.T. Road (Near TTD Administration Bldg.) Tirupathi 517 501. Jagadguru Kanchi Sri Chandrasekarendra Saraswathi Nethra Nilayam Sri City Sankara Nethralaya 21, Pycrofts Garden Road, Chennai 600 006. Sri City Medical Care Center, 305, North, 2nd street, Sector3, Dr. V. G. Appukutty Campus, Sri City, Varadaiahpalem Mandal, C.U. Shah Sankara Nethralaya & Chittoor Dist, AP - 517541. Jaslok Community Ophthalmic Centre. Academy - Elite School of Optometry, The Sankara Nethralaya Academy West Bengal No.8, GST Road, St. Thomas Mount, Chennai 600 016. Aditya Birla Sankara Nethralaya Navasuja Sankara Nethralaya No.147, Barakhola, Mukundapur, E M Bypass, (Near No.73, VenkataKrishna Iyer Road, Santhoshpur Connector Kolkata - 700 099. , Chennai 600028. Smt. T. K. Lakshmi Ammal and Smt. T.K. Sankara Nethralaya RSM Square No.10, Raja Subodh Mallik Square Alamelu Ammal Sankara Nethralaya Kolkata - 700013 New No 39. Old no. 19, 1st Main Road, East , Chennai 600 030. Kamalnayan Bajaj Sankara Nethralaya Suraj Sankara Nethralaya Premises No.25-3333, Plot No. D J 16, Action Area – 2, Kolkata - 700156 No. 34, Dharmaraja Koil Street, Post & Taluk, Tiruvannamalai Dt, Pincode 606801

10 MEDICAL RESEARCH FOUNDATION

ANNUAL REPORT FOR THE FINANCIAL YEAR 2019-20

I have great pleasure in presenting the 42nd Annual Report of the Medical Research Foundation.

FINANCIAL PERFORMANCE

The financial performance of the Foundation for the year 2019-20 is summarized below:

Description 2019-20 2018-19

INCOME (Rs in Lakhs) (Rs in Lakhs)

Hospital Collections 20736 20763

Grants and Other Income 2464 2474

Total Income 23200 23237

EXPENDITURE 22062 21431

Surplus before Depreciation 1138 1806

Depreciation 1841 1737

Net Surplus/Deficit (703) 69

The Hospital Collection this year was almost equivalent compared to 2018-2019. Due to COVID-19 pandemic, hospital was not in operation from 26th March 2020, which has affected the functions of the Foundation hence the growth in Income was not seen.

After meeting all the expenses including depreciation, Net Expenditure over Income was Rs. 703 lakhs compared to the Net Income over Expenditure of Rs. 69 lakhs of 2018-19.

11 MEDICAL RESEARCH FOUNDATION

CASH FLOW Description 2019-20 2018-19 Source (Rs in Lakhs) (Rs in Lakhs)

Cash flow from operations (703) 69

Add: Depreciation 1841 1737 Donations 3033 1912 ICICI KfW loan for St Thomas Mount 750 750 Increase / Decrease In Current Liabilities 829 (266)

Total Sources 5750 4202

Applications Investment - Capital expenditure 1990 850 Investment - Project (St. Thomas Mount) 1367 1059

Mukundapur Lease payment / 427 613 RA Puram Land & Building

ICICI Technology loan – Repayment 608 500

Total Applications 4392 3022

Cash Surplus/(Deficit) 1358 1180 Opening Cash Balance 8377 7197 Closing Cash Balance 9735 8377

Donations Donations received during the year amounted to Rs. 3033 lakhs. The corresponding figures for 2018-19 were Rs.1912 lakhs. Major grant received from H T Parekh Foundation for Rs.1495 lakhs.

Fixed Assets An amount of Rs 1849 lakhs for updating technology & replacements. An amount of Rs 141 lakhs is spent towards EDP/Software and also an amount of Rs 1367 lakhs spent towards New Community Hospital - St. Thomas Mount.

12 MEDICAL RESEARCH FOUNDATION

OPERATIONAL PERFORMANCE

DESCRIPTION NUMBERS YEAR 2019-20 2018-19

OUTPATIENT CONSULTATION 841187 870450

MAJOR OUTPATIENT PROCEDURE 125992 127765

SURGICAL PROCEDURE 60160 63905

Treatment of Poor Patients The number of free surgeries in the FY 2019-20 was 21017 against 22810 in FY 2018-19. Number of free surgeries as a percentage of total surgeries done was 35% in the FY 2019-20 and 36% in the FY 2018-19. The revenue foregone through free services and waiver / concessions amounts to Rs.4368 Lakhs. Last year the corresponding amount was Rs.4324 lakhs.

The reason for the slight decrease in the free surgeries is due to the closure of the Community Theatre for significant period of days in March 2020 due to COVID-19 pandemic lockdown.

DEPARTMENT ACTIVITIES EYE BANK

"The Details of Corneal Transplant services during the period April 2019 – March 2020 are as follows:

1. Total Number of eyes Collected: 1372 numbers against 1012 numbers in 2018 - 19

2. Total Number of Corneal Transplant surgeries performed: 656 numbers against 677 numbers in 2018-19

3. Amount Received from Reliance Dhristi Project towards performance of free corneal transplant: Rs. 2,02,500 (Rs. Two Lakh two thousand five hundred only)” pending amount 4,57,500. (Rs. four lakh fifty seven thousand five hundred only)

4. Amount received as Grant from NPCB (National program for control of blindness) during the Period Rs. 11,53,000 (Rs. Eleven lakh fifty three thousand only)

13 MEDICAL RESEARCH FOUNDATION

I. NABH Accreditation Status for Entire SN Sl. No SN Location Last Audit Date Accreditation Certificate valid Status From To 1 SN Main Campus 24th & 25th Feb’2018 Valid 20/12/2018 - 19/12/2021 2 JKCN 18th,19th & 20th Sep’2017 Valid 18/02/2018 - 17/02/2021 3 CU SHAH-ECO 7th & 8th June’2019 Valid 03/12/2019 - 02/12/2022 4 NSN 18th & 19th Aug’2018 Valid 20/12/2018 - 19/12/2021 5 RAJARHAT-SNK 23rd &24th Feb’2019 Valid 27/07/2019 - 26/07/2022 Kamalnayan Bajaj SN 6 Aditya Birla SN 3rd & 4th Nov’2018 Valid 29/04/2019 - 28/04/2022

II. Quality Activities carried out until lockdown:

1. Clinical & Managerial Quality Indicator Meeting with the top Management – conducted every month. 2. Patients feedback analysed and presented to the stakeholders and the top management 3. Patients complaints sorted within the timelines. 4. SOPs updated as per NABH norms for all the 6 centers. 5. CUSHAH’s accreditation status transited from Small Healthcare Organization to Eye Care Organization 6. Internal Audits conducted for all centers 7. Mandatory training is carried out as per the NABH standards for the SN employees and the out sourced employees. 8. The required data for NABH sent in appropriate periodicity for all centers.

IT & Systems SN takes pride in leveraging its investment in Information Technology & Systems. The technology investments have enabled SN to drive operational improvements in its business operations, improve efficiency besides sustainable patient care.

14 MEDICAL RESEARCH FOUNDATION

IT Infrastructure We are focused on providing highly resilient and trusted technology environment to sustain a technology driven business support to our entire operations. We have now a completely digitally enabled campus across most of our locations giving us capabilities to launch newer solutions for our internal users. Cyber security continues to be a bigger threat to provide a trusted IT environment for our users. We have been proactively managing the cyber security threats. We continuously monitor cyber security threats and keep a close watch on cyber security trends across the industry. Our Cyber warriors are active participants in cyber forums and learn and exchange best practices in cyber defense and have evolved cyber tactics to meet our specific needs. Our data stored in our servers, networks and end points are continuously hardened against any known vulnerabilities and we continue to take proactive measures to defend against any targeted or unknown cyber-attacks. An attempt is being made to develop the next generation of smart storage solutions for medical imaging. Coupled with AI driven solutions could transform the needs of EMR for enhanced decision making. A beta solution is under review. The SD WAN solutions developed in house continue to be under beta in view of network changes in various locations and are fine tuned for performance and diverse needs. We have seen positive results and will be rolled out progressively in major locations in the coming year. EMR & Hospital Management solutions SN IT has been collaborating with users to address their business needs to bring in innovation in their business processes and to provide improved operational efficiency in patient care. The engagements pursuits had resulted in enhancements to the HMS / EMR software. As part of our technology modernization program we have rolled out the SN-HMS-EMR into the current technology stack provided by Microsoft resulting in the following major benefits. 1. Enhanced data security 2. Multi browser support – leading to mobile compatibility for core applications 3. Cloud enablement for scale and agility 4. Enhanced application performance With the new release, it gives us the ability to integrate our services through seamless integration leveraging API services and bringing in transformation in how we can consume advanced digital capabilities provided by the Cloud and Specialized AI service providers.

15 MEDICAL RESEARCH FOUNDATION

Over the last one year we have rolled out new capabilities to our IT solutions. The areas of changes include the following: Ø Development of 100 + productivity tools to address application support and enabling users to manage their own needs. Ø Continued enhancements to EMR Ø Continued focus on enhancing operational efficiency in the administration systems in many areas which include Patient Billing, Insurance management, Optical, Central stores, Patient services, Patient services for Patient feedback and related reports and dashboards. Ø Worked closely with Finance teams to develop new capabilities for audit and compliance and Corporate billing. Ø Additional automation areas include improved work flows, automated data capture, patient tracking systems for time management, e-way bill systems for stock transfers and many more. Ø Enabled HR with smart internal tools significantly reducing end of the month processing for attendance and payroll processing. Ø Many of the key processes has been integrated with automated SMS, email alerts and exception driven reporting. Ø Service calls had been continually being reviewed proactive updates have been made to provide users with self-help capabilities and tools for improved decision making while servicing patient requests. Ø SN IT teams had been closely working with Google global development teams and engaged in developing new capabilities leveraging AI for Diabetic retinopathy, glaucoma and Retina.

4. Fund Raising activities SN OM Trust Awarded Highest Award by Charity Navigator

In September 2019, the SN OM Trust Inc USA, a leading Indian charity since 1988 and fund raising arm of Sankara Nethralaya was accredited as a 4 star charity by “Charity Navigator”, the highest rating for non-profits in the country. 'Charity Navigator’ is USA's leading assessment organization, which helps donors make well informed decisions and enables charities to exhibit their operational efficiency, compliance of norms and commitment to best utilization of donor dollars.

16 MEDICAL RESEARCH FOUNDATION

Sankara Nethralaya Seattle Chapter raises 25K with Microsoft Give

In 2019, Sankara Nethralaya entered the Microsoft Give campaign, wherein Microsoft matches 100% of donations and volunteer hours by employees to promote philanthropy across the organization. The Microsoft Give program generated around 25K, which in turn funds around 380 surgeries for patients with curable blindness. Sankara Nethralaya Seattle- Washington trustees Vishwanath Manchikalapati & JayaKiran Pagadala ex-Microsoft employee) helped organise a poker event in support of the Give Campaign. Bala Reddy Indurti (President) also attended to support the campaign.

SN OM Trust Atlanta Chapter raises $ 200k to support 3000 poor blind patients

The SN OM Trust organized an evening of entertainment by “Drishti” at the ‘Infinite Energy Center’ Atlanta, USA on 8th September 2020. The event raised $200,000 to support 3000 poor visually challenged patients. Atlanta Trustee Srini Reddy Vangimalla, Vice President Moorthy Rekapalli & President Bala Reddy Indurti addressed the audience about Sankara Nethralaya fundraiser events in different cities in USA and service activities in India. The fund raising team led by SN OM Trust President Bala Reddy, Indurti Moorthy Rekapalli, Srini Reddy Vangimalla, Rajasekhar Reddy Aila, Meher Lanka, JayaKiran Pagadala, Padmaja Kelam, Upendra Reddy Rachupally, Ramesh Chaparala, Rajeev Menon, Suresh Vemulamada & Neelima Gaddamanugu was responsible for raising such a huge amount to help the needy in India. Bala Indurti dedicated this victory to Atlanta Chapter founder Dr. Seshu Sarma.

17 MEDICAL RESEARCH FOUNDATION

Widower Donates in Wife’s Memory Not only did a grieving widower, Mr. MSS Raghavan contributed a cheque towards setting up an optometry room at the Sri A. Sivasailam Block in his late wife, Mrs Komala Raghavan’s memory. He has also bequeathed his house, where he spent his happiest years, to Sankara Nethralaya, a deeply touching and most unexpected benevolence.

Major CSR supporters in Financial Year 2019-20

1. M/s. Bharat Petroleum Corporation Ltd 2. M/s. Blue Cross Laboratories Pvt Ltd, Mumbai 3. M/s. Computer Age Management Services Pvt Ltd, Chennai 4. M/s. HDB Financial Services Limited, Mumbai 5. M/s. H T Parekh Foundation, Mumbai 6. M/s. The Clearing Corporation of India Limited, Mumbai 7. M/s. Kansai Nerolac Paints Limited, Mumbai 8. M/s. Standard Chartered Global Business Services Private Limited, Chennai 9. M/s. Star Health and Allied Insurance Co.Ltd., Chennai 10. M/s. Safina Towers Pvt Ltd., Bangalore 11. M/s. Universal Comfort Products Limited, Uttarakhand 12. M/s. L & T Technology Services Pvt Ltd, Chennai 13. M/s. Bharat Heavy Electricals Ltd., Chennai 14. M/s. VLS Capital India Pvt Ltd, New Delhi 15. M/s. Genpact India Pvt Ltd, Haryana

18 MEDICAL RESEARCH FOUNDATION

Major CSR supporters in Financial Year 2019-20

Sl. No Name of the company Supported Supported for Since

1. M/s Computer Age 2002 Free Cataract and complicated major Management Service Limited surgeries. Eso Occupational Optometry Eye Examination

2. M/s Bharat Petroleum 2020 Community hospital – Equipment and naming Corporation Ltd an Operation Theatre

3. M/s HDB Financial Services 2018 Rural camps, Cataract surgeries, Bus, Limited Equipment, New community hospital building project 4. M/s The Clearing Corporation 2017 MESU, Equipment, Major surgeries, SNEHAM Of India Ltd project

5. M/s Standard Chartered 2004 Teleophthalmology Camps, Cataract surgeries, Globalbusiness Services Pvt Ltd MESU, Equipment, Bus, Spectacles

6. M/s Larsen And Toubro Ltd 1980 Naming a Department, Teleophthalmology, MESU

7. M/s H T Parekh Foundation 2015 Complicated free major surgeries, Equipment, Community Operation theatre in Kolkata, MESU, Ocular Oncology Centre Kolkata, COVID 19 Safety items

19 MEDICAL RESEARCH FOUNDATION

HUMAN RESOURCES AND DEVELOPMENT The Employee’s strength as on 31st March 2020 is 1583 (31st March 2019 was 1560)

Particulars As on 31.03.2020 As on 31.03.2019 Consultants * 154 153 Executives & Optometrists 535 552 Staff 894 855 TOTAL 1583 1560 *Includes Ophthalmologists, Physicians and Anesthetists The Human Resources Department carried out its function of recruitment, orientation for new recruits, assessment of employee health and safety and implementing welfare measures as per Institutional policy. The performance appraisal of the employees was carried out through the metrics of Rubrics. Training programs were conducted throughout the year. The training modules were classified into Technical programs, sessions on soft skills and the mandatory sessions that are required as part of NABH compliance.

AWARD AND RECOGNITION TO OUR FOUNDER & CHAIRMAN EMERITUS DR. S. S. BADRINATH "The Most Admired Gandhian of Tamil Nadu Award" by Senior Citizens Group of Besant Nagar on 1st November 2019 at Chennai.

SANKARA NETHRALAYA’S SERVICE AT TIRUPATI THROUGH SRI SRINIVASA SANKARA NETHRALAYA The Sri Srinivasa Sankara Nethralaya (SSSN) which was established in the year 2009 by Sri Srinivasa Sankara Nethralaya Trust by Tirumala Tirupati Devasthanams (TTD). This center has screened more than 10,665 new patients and has performed 3,503 cataract surgeries during the financial year 2019 - 20 (FY 2018 -19: 11,983 new patients and 4,210 surgeries). Mission for Vision Trust is playing a major role in mobilizing patients for free cataract surgeries at SSSN.

20 MEDICAL RESEARCH FOUNDATION

ABOUT OTHER CENTRES OF SANKARA NETHRALAYA 1. Aditya Birla Sankara Nethralaya & Kamalnayan Bajaj Sankara Nethralaya, Kolkata, West Bengal: (i) Aditya Birla Sankara Nethralaya, Kolkata, West Bengal: This center has screened more than 61,820 new patients and performed 5,570 surgeries during the financial year 2019 - 20. (FY 2018 -19: more than 75,773 new patients and 9,578 surgeries). It provides comprehensive eye care under one roof along with diagnostic and therapeutic treatment facilities and acts as a regional referral center for patients from North Eastern region of India. We have a dedicated team of 18 medical professionals and 179 non-medical support team along with 77 outsourced personnel to manage this center. We are happy to share with you that this center was recently accredited with NABH certification under Eye Care Organization standards. (ii) Kamalnayan Bajaj Sankara Nethralaya, Kolkata, West Bengal This center has screened more than 43,963 new patients and performed 7,856 surgeries during the financial year 2019 - 20. (FY 2018 -19: more than 39,099 new patients and 5,630 surgeries). This center has facilities to provide comprehensive eye examination along with top class facilities for all diagnostic and therapeutic treatment modalities. This center is managed by a dedicated team of 12 medical professionals along with 131 non- medical support team and 78 outsourced personnel. We are happy to share with you that this center too was recently accredited with NABH certification under Eye Care Organization standards. 2. Sankara Nethralaya, Sricity, Tada, Andhra Pradesh: Our center at Sri City, catering to the needs of industrial workers and also the needs of the villagers living around this upcoming industrial town, has rendered services to more than 5,856 patients and has performed 84 cataract surgeries during the financial year 2019 – 20 3. Suraj Sankara Nethralaya, Chetpet, Tiruvannamalai District, Tamil Nadu: Suraj SN assumes great importance as it would be dispensing world class eye care in a semi urban region and serving a large number of indigent patients from the neighboring villages, who do not have access to quality eye care. This center has screened more than 5,870 new patients and has performed 458 cataract surgeries during the financial year 2019 - 20 (FY 2018 -19: 3,358 new patients and 73 Cataract surgeries). In the land mark year 2020, Sankara Nethralaya initiated a unique program SNEHAM 2020, to mark the 150th Birth anniversary of Mahatma Gandhi and the World Sight day. Combining the visionary dream of Mahatma for villages, this project envisions equitable comprehensive eye care to the rural villages. This scheme aims at providing 20/20 vision to every citizen in 150 villages of the district of Tiruvannamalai.

21 MEDICAL RESEARCH FOUNDATION

CONCLUSION Financial Year 2019 – 2020 saw the Foundation stepping into its’ 42nd year of Service to our country. Under the inspiring and visionary leadership of Dr. Badrinath, the year saw the Foundation embarking on new projects and expansion of its services besides setting a new record in financial performance and a new record in number of free services performed. True to its founding principle, the Foundation showed growth in all its areas of activity - World class eye care, Community Services, Research and Education – broadly recognized as the four pillars of the Foundation. The year brought in a new President of the Foundation – Dr. Girish S. Rao – who assumed the mantle of President with the blessings and approval of his mentor Dr. S. S. Badrinath and the Board members. An Ophthalmology student of Sankara Nethralaya, Dr. Rao brings in both clinical experience and Administrative experience to the job. With the resignation of Hony Treasurer, I took over the additional charge of Hony. Treasurer till a new person is elected. The Hospital Collection this year was almost equivalent compared to 2018-2019. The impact of the pandemic was seen from the 3rd week of February, with patient flow reduced to 50% from the 1st of March. Both out-patient and in-patient services were affected and should a sharp decline for the month of March 2020. With the lockdown being announced, the hospital was closed and not in operation from 26th March 2020, which has affected the functions of the Foundation hence the growth in Income was not seen. After meeting all the expenses including depreciation, Net Expenditure over Income was Rs. 703 lakhs compared to the Net Income over Expenditure of Rs. 69 lakhs of 2018-19. The hospital has been functioning throughout the lockdown offering emergency as well as regular outpatient and inpatient care to both paying and free patients. 2019-2020 proved a record year for donations. Donations received during the year amounted to Rs.3033 lakhs. The corresponding figures for 2018-19 were Rs.1912 lakhs. Major grant received from H T Parekh Foundation for Rs.1495 lakhs helped in the upgradation of the cataract operation theaters in all SN centres – both Chennai and Kolkata. Further, HTP Foundation supported the construction of the new Academic block in VG Appukutty campus to house The Sankara Nethralaya Academy. Large grants / donations were also received from the Clearing Corporation of India, HDB Financial Service, Bharat Petroleum and L&T Technology Services. SN OM trust also had a good donation drive. With clinical work, academics and research marching ahead with full speed, 2019-2020 was a busy and productive year for the organization. Due to the prevailing pandemic situation, Sankara Nethralaya, who has always been an innovator and pioneer in eye care, reached out to its patient base through Tele-counselling and Tele-consultation. A tie-up with Titan Eye plus has been initiated to reach out to patients across the country who are currently unable to travel to Chennai or Kolkata for expert advice and care.

22 MEDICAL RESEARCH FOUNDATION

During the year, 60 Ophthalmologists got trained through the various Ophthalmology post graduate and fellowship programs. In total 2282 Ophthalmologists have been trained by Sankara Nethralaya. This is a proud achievement of the institution and reaffirmation of the Vision of Dr. Badrinath. Further, another 150 students graduated from different programs including Optometry, Medical Laboratory Technology, Business Administration, Nursing and Ophthalmic Dispensing. These are all indicators of the robustness of Sankara Nethralaya’s academic activities. Research work at Sankara Nethralaya has helped produce 2 Ph. D graduates this year. A further 15 students are pursuing their Ph.D. Numerous projects in Optometry (Binocular vision, Contact Lens and Myopia) and Ophthalmology (Dry eye, Keratoconus, Diabetic Retinopathy and Glaucoma) are being carried out. A number of papers have been published on the research outcome in peer reviewed Indian and International journals. REACH – a school screening project supported by Orbis was completed this year. The 3-year project helped to screen 3 lakh school children studying in Corporation and government aided schools across Kanchipuram, Chennai and districts. The unique feature of the screening was inclusion of Binocular Vision Screening – the first of its kind in the world. 5% of the children required spectacles which were distributed through the project. HUMAN RELATIONS: The Founder, Dr S S Badrinath and Dr Vasanthi Badrinath are the real force behind this great institution, continuously guiding and monitoring the progress of the institution in every sphere. Their concerted actions in the continuous development of Consultants and their professional management style with succession plans have started yielding results. Dr Girish S. Rao, Medical Director – Administration & Vice-President, MRF has moved comfortably into the role of heading the administration of the hospital under the guidance of Dr. Badrinath. With the support of Chairman Emeritus and the Administration team, he is working on managing the hospital functions. The Vice Chairman, Dr T S Surendran, Medical Directors / Senior Consultants Dr. Prema Padmanabhan, Dr Pramod Bhende and Dr L Vijaya, Dr J Biswas all share a common vision as that of the Founder, Dr S S Badrinath, which helps to continue the successful functioning of the Organisation. Quality administrative support is provided by Dr K S Vasan, the M.D., ably assisted by Ms. Akila Ganesan, Director Administration and Ms Susila Girisan, DGM – Finance. The Board Members continue to render their expert guidance to ensure the smooth functioning of the Organization. Our entire para medical and administrative staffs are an important link between the patients and the institution. They ensure the smooth functioning of the Organization. Regular training classes are being held to some of these groups.

23 MEDICAL RESEARCH FOUNDATION

The pandemic has affected the financial position of MRF in 2 ways: Decreased patient flow and increased expenses due to the purchase and usage of COVID safety items. Understanding the headwinds that the organization would face, the Management worked diligently right from May 2020, to reduce the cost and increase the donation drive. Salary cut was implemented from July 2020. Financial discipline over the last 6-7 years had helped to create a strong rainy day fund of Rs. 97 crores. All these factors have helped in tiding over this very difficult situation. I record with gratitude the support of the dedicated Board of Management who despite their other priorities have always come forward to advise the Institution whenever needed even at very short notices. Our auditors, since the beginning of this institution, M/s S. Viswanathan & co. are carrying out their assignment as a service to a non-for-profit organization for a token compensation. I record with appreciation the personal involvement of the partners Mr. Chella K Srinivasan and Mr. R. M. Narayanan. The internal auditors M/s Profaids are also very dedicated in their service to us. I thank them for their personal involvement in our case. SWAN, the women auxiliary wing of our organization is continuing their good service to Sankara Nethralaya. Their contributions to the welfare of indigent patients treated at Nethralaya are praise worthy. I salute these dedicated ladies guided by Ms. Surekha Ben, Mrs. Appukutty, Mrs. Haridas and many more. Our bankers, HDFC and SBI, are very considerate in taking up our requests and delivering their service very promptly to us. I thank them for their support. At this juncture, I need to extend my sincere gratitude to our Major Donors during this financial year – Clearing Corporation of India, HDB Financial Services, HT Parekh Foundation, Tata Trusts, Computer Age Management Services Private Limited, Bhabani Pigments Private Limited, Binaguri Tea Company Private Limited and the TVS Group. They have supported the Community Services of Sankara Nethralaya through large grants and donations. I would also like to extend my gratitude to the numerous other donors who have been the pillars of support for our work. I thank the following partners for our community work for their help in taking care of our indigent patients - Mission for Vision, Sri Shridi Sai Trust, Sri Sai Darshan Trust and Lions Club.

G. RAMACHANDRAN Hony. Secretary & Treasurer

24 MEDICAL RESEARCH FOUNDATION

ACADEMICS During the year 2019-20 , MCI , New Delhi has converted the Post Graduate Diploma in Ophthalmology(2 years) course to M S Ophthalmology (3 years) Course. The course will start from the academic year 2020. Number of people trained by Sankara Nethralaya in Ophthalmology so far are: A total of 2282 Ophthalmologists are trained

DO : 107

DNB : 214

Ophthalmology Fellows : 1125

Advance Cataract Fellows : 783

PhD (Ophthalmology) : 03 (Ph D from BITS University & The Tamilnadu Dr M G R Medical University)

B.S. Optometry : 676

M Phil Optometry : 112

MSMLT (BITS, PILANI) : 96

*PhD (Optometry) : 10 PhD (Ophthalmology)

* Ph.D. (Microbiology, Biochemistry Genetics, Pathology) : 56 (Ph D from BITS, The Tamilnadu Dr M G R Medical University, Sastra University & Deakin University Australia)

FRCS Edinburgh : 50 During the year of 2019-2020 total number of PG’s ,fellows and others trained. Total No of Students completed their Program

Ophthalmology Fellowship Programme : 40

Cataract Fellowship : 07

DO : 3

DNB : 7

Observer, other ophthalmology training : 3 National Board of Examination, New Delhi has increased the seats for DNB (Post MBBS) and DNB (Post Diploma) from 5 seats to 10 seats. (Each Programme has the capacity of seat 10 Numbers) during the year 2019-20 onwards.

25 MEDICAL RESEARCH FOUNDATION

THE SANKARA NETHRALAYA ACADEMY The Sankara Nethralaya Academy, an academic wing of Sankara Nethralaya, offers distinct programs in Allied Health Sciences at various levels. We strive to uphold the philosophy of inclusive service to the community by making the quality education affordable for the weaker segments of the society. We also extend hostel and mess facilities, either subsidised or totally free, for the needy girl-students. PROGRAMS OFFERED l Affiliated to TN Dr.MGR Medical University w M Optom w MHA (AHS) w MSc (Medical Laboratory Technology) w BSc (Medical Laboratory Technology) w Diploma in Optometry l In collaboration with Periyar University w BSc (Ophthalmic Dispensing &Vision Science) l In collaboration with Hindustan Institute of Technology & Science (Deemed to be University) w MBA (Hospital & Healthcare Management) w BBA (Hospital & Healthcare Management) l In collaboration with ITM University, Raipur w M Optom FELLOWSHIP PROGRAMS l Fellowship in British Dispensing Opticians from the Association of British Dispensing Opticians, UK l Work Integrated Fellowship in Clinical Optometry l Fellowship in Clinical Optometry /Low Vision /Contact Lens /Binocular Vision /Vision Therapy /Neuro Optometry /Ocular Prosthesis /Optical Dispensing (Basic) SHORT TERM /DISTANCE PROGRAMS l Continuing Optometry Education /Medical Education l Post Graduate Program in Hospital Management /Optical Retail Management l Certificate in Optical Retail Management /Hospital Infection Control /Hospital Management /Hospital Finance Management /Hospital Quality Management

26 MEDICAL RESEARCH FOUNDATION

Highlights of the Year l Shifted to our own premises at Dr.VG Appukutty Campus, St. Thomas Mount, Chennai, in November 2019, with enhanced facilities.

l Our students’ demographics is dominated by girl-students, to the extent of 85%. l With the support from philanthropists, extended full /partial course-fee waivers for 30 students besides full /partial hostel /mess-fee waivers for 40 students l Organized Corporate Training Program for 30 security staff of NLC India Ltd. l Commenced the first batch of MOptom, offered in collaboration with ITM University, Raipur. l 13 students completed FBDO (3 years program) during this year. l First batch of BSc (OD) completed the course, out of which 13 students have been placed in Sankara Nethralaya. l BSc (ODVS) (3rd and 4th year) students were part of over 50 REACH & SNEHAM camp conducted by SN/ESO. MOptom students played a major role in over 7/12 TTD camps conducted by ESO team.

27 MEDICAL RESEARCH FOUNDATION

Ø In SN-Kolkata, introduced Fellowship programs in Optical Dispensing (Basic), Clinical Optometry and WIFCO. l Degree Certificates distribution ceremony held in January 2020 for 42 students of B.Sc (OD) and 15 students of B.Sc (MLT). l Our students participated, and some of them got prizes, in various seminars /conferences /workshops /training programs organized by different institutions /organizations. l In the state level phlebotomy competitive exam conducted by Indian Association of Basic and Paramedical Sciences, our students grabbed all the three awards. l As a part of our community service, our students visited orphanages /senior citizens homes for spending time with their routine. l Organized one day workshop on Getting Employment by Choice Rather Than by Chance for final year UG students of various institutions. l Organized Essay & Oratorical competition for XI & XII students on the eve of 137th Birthday Anniversary of Mahakavi Subramanya Bharathiyar. l 100% Results in the end semester examination conducted by Hindustan Institute of Technology & Science (Deemed to be University). l 100% Placement for outgoing students of MHA, MBA & BBA courses. l Members of ROTARACT Club of TSNA, under the auspices of Rotary Club of Madras East, participated in various community service programs, reaching out to those in distress. l Binocular Vision Anomalies in Keratoconic Patients authored by Sushmitha AD was published by the Optometry and Vision Science Journal of the American Journal, American Academy of Optometry. l COVID-19 Limiting the Risk for Eyecare Professionals was authored by Soumen Sadhu in Ocular Immunology and Inflammation published by Taylor and Francis Group.

28 MEDICAL RESEARCH FOUNDATION

Educational Activity of Vidyasagar Institute of Biomedical Technology & Science (VIBS) (JULY 2019- JUNE 2020) VIBS was established on 25th October 2006 to promote research including fundamental research and foster biomedical technology and science in Basic Medical Sciences. I Ph.D. Programme: 1.Number of Ph. D. Awardees: - (July 2019 – June 2020) = 2 (SASTRA Deemed to be University, Thanjavur – 2)

a)Number of candidates obtained Ph.D from SASTRA deemed to be University, Thanjavur = 1 S.No. Candidates Name Title Supervisor External Date of Examiner Viva-Voce Examination 1. Mr. Ravikanth Danda “Identification of Novel Dr. S. Krishna Prof .Usha Kim, 12th (ID No: PH 510) therapeutic target Kumar Chief, Orbit, December molecules in Professor & HOD Oculoplasty and (Stem cell Retinoblastoma” 2019 Laboratory) (L & T Ocular Pathology Ocular Oncology department & Incharge Services, Director of Nano Biotechnology & Stem cell biology departments)

2. Mr. K.Anand Babu "Role of paraoxonase in Dr.Angayarkanni Dr.K. Dharma 17th (ID No: PH 615) oxidized LDL – Narayanasamy lingam February Mediated Pathogenesis (Professor & Head of Director-Research, (R.S.Mehta Jain of age related 2020 Department of R.S.Mehta Jain Aravind Medical molecular degeneration Department of Research Biochemistry & Cell (AMD): in vivo studies Biochemistry & Cell Foundation, biology) in AMD patients and in biology) Madurai. vitro studies in human retinal pigment epithelial cells”

29 MEDICAL RESEARCH FOUNDATION

II) Ph.D Candidates (16 undergoing Ph.D. + 1 - in the process of submission of final thesis + 7 submitted Ph.D. Thesis) under 4 different National Universities:

S.No Basic Medical Alagappa SASTRA Deemed Tamilnadu Alagappa Sciences University, to be University, Dr.MGR Medical University, Departments, Karaikudi Thanjavur (12) University, Karaikudi KNBIRVO Block Chennai (N =24) Undergoing Ph.D. Thesis In the process undergoing undergoing Ph.D. Programme submitted & of Submission of Ph.D. Ph.D. (10) awaiting viva (7) final thesis Programme Programme (1) (3) (3)

1. L & T. Ocular 2 1 - - 2 Pathology Department (N=5) 2. Nano Biotechnology - 1 - - 1 Department (N=2) 3. SN ONGC Department 3 1 - 2 - of Genetics & Molecular Biology (N=6)

4. R.S. Mehta Jain 4 2 1 - - Department of Biochemistry and Cell Biology (N=7) 5. Centre for 1 2 - 1 - Bioinformatics (N=4)

2. A) No. of Candidates Submitted Ph.d Thesis & Awaiting Public Viva- voce: Sastra Deemed To Be University, Thanjavur: (N =7) S.No. Candidates Name Title of Ph.D. Thesis Supervisor’s Name Date of Final submission of Ph.D. Final thesis 1. Ms. Bhavna S Rao “Fuchs’ endothelial Dr.N. Soumittra 21st June 2019 (ID No: PH 684) corneal dystrophy - (Faculty, SN ONGC (SN ONGC Department genetic analysis using Department of Genetics whole genome & Molecular Biology) of Genetics & sequencing, association Molecular Biology) study and candidate gene screening”

2. Mr.R.N.Naresh kumar “Molecular mechanism Dr.K. Coral Miriam 21st June 2019 (ID.No: PH 718) of the anti angiogenic (Faculty, R.S.Mehta Jain (R.S.Mehta Jain and anti tumorigenic Department of potential of Lysyl Biochemistry & Cell Department of Oxidase Propeptide Biology) Biochemistry & Cell (Lox-PP)” biology)

30 MEDICAL RESEARCH FOUNDATION

S.No. Candidates Name Title of Ph.D. Thesis Supervisor’s Name Date of Final submission of Ph.D. Final thesis 3. Ms. P. Karthikka “Functional Dr.C.Subbulakshmi 21st June 2019 (ID No: PH 528) characterization of (Faculty, Vision adiponectin in the Research Foundation) (R.S.Mehta Jain molecular events Department of preceding the onset of Biochemistry & Cell diabetic retinopathy” biology)

4. Mr.S.Muthukumaran “Computational design, Dr.V.Umashankar 21st June 2019 (ID No: PH 719) synthesis and validation (HOD of Centre of (Centre for of potential inhibitors Bioinformatics, Vision targeting human Research Foundation) Bioinformatics) Ornithine decarboxylase (ODC) to modulate polyamines in retinoblastoma cells”

5. Mr. Arun John “In silico design of Dr.V.Umashankar 2nd March 2020 (ID No: peptide and chemical (HOD of Centre of PHBIFE1504903) inhibitors targeting Bioinformatics, Vision carbonic anhydrase IX Research Foundation) (Centre for mediated pH Bioinformatics) homeostasis in cancer cell and in vitro validation of inhibitory efficacies”

6. Ms. Vidya Gopakumar “Generation of corneal Dr.S.Krishnakumar 25th May 2020 (ID No: PH 511) epithelial cells from (HOD of L & T Ocular (Stem Cell noncorneal autologous pathology Department, source for the Laboratory) Incharge of Stem cell & treatment of bilateral Nanobiotechnology limbal stem cell departments) deficiency”

7. Mr.Amit Chatterjee “Understanding the Dr.J.Narayanan 4th June 2020 (ID No: mechanism of cell (Associate Professor PHBIOFE1404812) penetrating peptide Department of using kerataconus Nanobiotechnology) (Department of epithelium as clinical Nanobiotechnology) model”

31 MEDICAL RESEARCH FOUNDATION

(ii) The Tamilnadu Dr. M.G.R. Medical University, Chennai: (N=1)

S.No. Candidates Name Title Supervisor Date of 23 Draft Thesis submission

1. Ms. Rebecca Manohar "Elucidating the disease Dr.Angayarkanni 1st (Reg. No. 141510008) mechanism associated Narayanasamy October (R.S.Mehta Jain with Elastogenesis in (Professor & Head of 2018 Department of Pseudoexfoliation R.S.Mehta Jain Department syndrome: An in vitro and of Biochemistry & Cell Biochemistry & ex vivo study” biology) Cell biology)

IV. Master of Science (MS By Research) Programme: Number of Candidates Completed MS Programme in Research:(N=2)

S.No Candidate Name Topic Supervisor & Joint Registration Final viva Supervisor Month & voce Year 1. Mr.Ranjith kumar R “3D cancer tissue Supervisor: January 2017 29th (ID No: 17145281102) growth on graphene Dr.Tamilselvan October sponges for cancer Asst.Professor, 2019 drug therapy” Centre for Biotechnology, , Chennai Joint Supervisor: Dr.Sailaja V. Elchuri Associate Professor, Dept., of Nano- biotechnology

2. Mr. Hemanth R “Circulating Supervisor: January 2017 November (ID No:17145281106) exosomal miRNA Dr.Devasena T 2019 in serum as Associate Associate biomarkers for Professor, Centre for Retinoblastoma” Nanoscience & TechnologyAnna University, Chennai Joint Supervisor (Applied & awaiting communication) Dr.S.Krishnakumar HOD L & T Ocular pathology, Nano- biotechnology Depts.

32 MEDICAL RESEARCH FOUNDATION

V. OTHER EDUCATIONAL ACTIVITIES CONDUCTED AT VIBS : Short term Research Projects for PG students in Biological sciences: 30 students underwent VIBS – Short term projects from “December 2019- March 2020” in the 5 Basic Medical Sciences departments, as part of their academic programme from 10 Engineering Colleges & 2 Arts & Science Colleges.

S.No. Basic Medical Sciences Department No. of students (30) 1. L & T Microbiology Research Centre 6 2. R.S. Mehta Jain Department of Biochemistry & Cell Biology 8 3. Centre for Bioinformatics 4 4. SN ONGC Department of Genetics & Molecular biology 8 5. Department of Nano Biotechnology 4

VI. Specific Training programmes on specialized/advanced Techniques such as PCR/PCR RFLP, RT- PCR, ELISA, HPLC etc. (In the year July 2019 – June 2020) 5 students underwent Special Training programme in the Basic Medical Sciences departments from 2 Arts & Science Colleges & 3 Engineering Colleges

S.No. Basic Medical Sciences Department No. of students (5) 1. L & T Ocular Pathology Department 1 2. SN ONGC Department of Genetics & Molecular biology 1 3. L & T Microbiology Research Centre 1 4. R.S.Mehta Jain Department of Biochemistry & Cell Biology 2

33 MEDICAL RESEARCH FOUNDATION Independent Auditor's Report To the Members of MEDICAL RESEARCH FOUNDATION for the year ended 31st March 2020. Medical Research Foundation

Report on the Financial Statements We have audited the accompanying financial Statements of MEDICAL RESEARCH FOUNDATION which comprises the Balance Sheet as at 31 March, 2020, and the Income and Expenditure account for the year then ended, and a summary of significant accounting policies and other explanatory information. Management’s Responsibility for the Financial Statements Management is responsible for the preparation and presentation of these financial statements that give a true and fair view of the financial position, financial performance of the foundation in accordance with the Accounting Standards. This responsibility includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the foundation and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error. Auditor’s Responsibility Our responsibility is to express an opinion on these financial statements based on/ our audit. We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered Accountants of India (ICAI). The Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement. An audit involves performing procedures to obtain audit evidence about the amounts and the disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the foundation’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances but not for the purpose of expressing an opinion on whether the foundation has in place an adequate internal controls system over financial reporting and operating effectiveness of such controls. An audit also includes evaluating the appropriateness of the accounting policies used and the reasonableness of the accounting estimates made by the management, as well as evaluating the overall presentation of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion. Emphasis of Matter Impact of COVID-19: (a) We draw attention to Note: IV of the financial statements, which describes the effect of COVID-19 pandemic. The Hospital was not in operation from 26th March 2020, which has marginally affected the functions of the foundation. It is not appropriate to estimate the duration and severity of these consequences, as well as their impact on the financial position and results of the foundation for future periods.

34 MEDICAL RESEARCH FOUNDATION Independent Auditor's Report (b) Due to Covid-19 related lockdown, we wee nrot able to physically observe the physical verification of inventory that was carried out by the management at the year end. Consequently, we have performed alternate procedures to audit the existence and condition of inventory as per the guidelines provided in SA 501 “Audit evidence - Specific consideration for stipulated items’, which includes inspection of supporting documents relating to purchases and sales to issue our unmodified opinion on the financial statements. Debtor’s confirmation: In the case of sundry debtors, we have not been provided with the confirmation of balance from debtors and hence unable to comment over it. Our opinion is not modified in respect of above matters. Opinion In our opinion and to the best of our information and according to the explanations given to us, the financial statements give the information required by the act in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India. a) In the case of the Balance Sheet, of the state of affairs of the Foundation as at March 31, 2020. b) In the case of Income and expenditure account, of the Excess of expenditure over income for the year ended on that date.

For M/s. S.VISWANATHAN, LLP Chartered Accountants Regn No.: 004770S / S200025 Chella K. Srinivasan Place : Chennai Partner Date : 26.09.2020 Membership No.:023305

35 MEDICAL RESEARCH FOUNDATION

BALANCE SHEET AS AT 31st MARCH 2020

PARTICULARS SCHEDULE AS AT 31.03.20 AS AT 31.03.19

Rs. Rs. Rs. Rs. LIABILITIES CORPUS FUND DONATION u/s 35AC As per Last B/S 272906563 272906563 272906563 272906563 SIR RATAN TATA TRUST CORPUS FUND SRTT CORPUS FUND 65834003 65052186 MRF CORPUS FUND 54546664 120380667 53926957 118979143

GENERAL FUND I 2558494730 2316844816 EARMARKED FUNDS II 9881341 2077982 NON CURRENT LIABILITIES ICICI TermLoan (TI-Project) 239200000 225000000 Gratuity Liability 109854400 88254763 Leave Encashment Liability 87860691 436915091 74421443 387676206

Current Liabilities & Provisions III 201926283 191044425

TOTAL LIABILITIES 3600504675 3289529135

ASSETS FIXED ASSETS IV Gross Block As on 31.03.2020 3989926864 3521110120 Depreciation 2037682594 1853541101 Net Block 1952244270 1667569018 Fixed Assets not put in use Capital Work in Progress - 89344590 Net Fixed Assets as on 31.03.2020 1952244270 1756913609

Investments V 410623409 405136425

Current Assets VI 1237636996 1127479101 TOTAL ASSETS 3600504675 3289529135

We declare that the particulars furnished above are true and correct to the best of our knowledge and belief. RAMACHANDRAN G. DR. GIRISH S. RAO AKILA GANESAN Hony. Secretary & Treasurer President Director - Administration Examined and found correct as per the books maintained by Medical Research Foundation (Regd.) Chennai. M/S. S. VISWANATHAN, LLP Chartered Accountants 17, Bishop Wallers Avenue (west) Regn, No. 004770S/S200025 C I T Colony, , Chennai 4 CHELLA K. SRINIVASAN DATE : 26.09.2020 Partner M.No. 023305

36 MEDICAL RESEARCH FOUNDATION

INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31.03.2020

P AR TICULARS 31.03.2020 31.03.2019 Rs. Rs. INCOME SCHEDULE

Hospital Collections 2073555675 2076351715 Non Corpus Donations 48804999 53331818 Grants 17076359 22815377 Interest 95816719 77794512 Other Income 66228146 73764819 Research Income 18555935 19668901

TOTAL 2320037833 2323727142

EXPENDITURE Salaries, Wages & Employee Benefits VII 952937014 884360131 Hospital Expenses VIII 1007994955 1015284293 Administration Expenses IX 225338116 234561569 Interest X 5292444 2228357 Research Expenses XI 14621997 6683335

TOTAL 2206184526 2143117684

Surplus before Depreciation 113853307 180609458

DEPRECIATION 184141492 173749171

EXCESS OF EXPENDITURE OVER INCOME 70288185 (6860287)

We declare that the particulars furnished above are true and correct to the best of our knowledge and belief.

RAMACHANDRAN G. DR. GIRISH S. RAO AKILA GANESAN Hony. Secretary & Treasurer President Director - Administration Examined and found correct as per the books maintained by Medical Research Foundation (Regd.) Chennai.

M/S. S. VISWANATHAN, LLP Chartered Accountants 17, Bishop Wallers Avenue (west) Regn, No. 004770S/S200025 C I T Colony, Mylapore, Chennai 4 DATE : 26.09.2020 CHELLA K. SRINIVASAN Partner M.No. 023305

37 MEDICAL RESEARCH FOUNDATION

SCHEDULES TO BALANCE SHEET AS AT 31st MARCH 2020

PARTICULARS AS AT 31.03.2020 AS AT 31.03.2019

Rs. Rs. Rs. Rs. SCHEDULE 1 GENERAL FUND As per Last B/S 2316844816 2045565855 Less : Amount transferred to Earmarked Fund 4296774 1386000 Add : Amount transferred from Earmarked Fund 1500000 50000000 Add : Donations received during the year 314734873 215804673 Add : Excess of Income Over Expenditure 70288185 (6860287) Less : Excess of Expenditure Over Income Total General Fund 2558494730 2316844816 SCHEDULE II EARMARKED FUNDS Sir Ratan Tata - Phase III 30962 30962 SN Mahema Devadoss Endowment Fund 6750000 1266373 Sri Ramdoss Bhavani Nethralaya Endowment 100000 100000 Dhingra Family Trust - Fund 1000000 1000000 Dr. Nirmalasubramaniam Endowment Fund 254000 254000 Dr. Raja Gopal Endowment Fund 132000 132000 Subramanyam G Endowment Fund 1000000 1000000 Trent Ltd - 1500000 Orbis Project (1544747) 762111 Navajbai Ratan Tata Trust (1340874) (6467464) MRF Limited 2500000 2500000 Renuka Devi Endowment Fund 500000 - Sivasankari Chandrasekaran Endowment Fund 500000 - Total Earmarked Funds 9881341 2077982 SCHEDULE III

CURRENT LIABILITIES & PROVISIONS Sundry Creditors - Suppliers 136200863 132980276 Sundry Creditors - Bills payable 15456056 12356862 Sundry Creditors - (Deferred Payment) 6891412 12228601 Salary Payable 3144312 4504186 Security Deposit - Others 20000000 20000000 Employees Benefit /Contingency/ 8570297 2392255 Common Good Fund Others 11663343 6582245

Total Current Liabilities & Provisions 201926283 191044425

38 - Rs. 64793 12780 as at 3232267 31.03.20 10139313 30306445 44738765 34265032 42992299 20582569 286295755 176460866 856099890 447053497 1756913609 1952244270 1952244270 Rs. BLOCK 18253 71996 as at 342662 NET 8807241 3349079 31.03.19 94281845 44486539 35986380 20710610 30959884 275399655 127151672 402828548 717456500 1667569019 1659442480 1761850864 - - - Schedule - IV Rs. TION as at 271643 342615 1145484 31.03.20 86593455 26300752 16248749 51078199 76391170 369660772 149515566 194008466 1853541101 1066125723 2037682594 2037682594 - - Rs. 5476 7200 otal T 539706 5879961 2201961 4852673 5993247 2019-20 97991125 10269615 16052928 40347600 173749171 184141492 184141492 ------THE Deletion FOR YEAR 2019-20 - Rs. THE TION 26091 266291 141788 234376 732060 FOR 2ND HALF 4474775 1354585 3198450 7961800 YEAR 2019-20 11017798 21446214 21446214 Depreciation - Rs. DEPRECIA 5476 7200 THE HALF 513615 RESEARCH FOUNDA 5738173 9537555 4638662 1854478 1935670 FOR 8697327 4618297 1ST 35872825 YEAR 2019-20 165787371 Depreciation 162695278 162695278 - Rs. ill T 264443 342615 1140008 31.03.19 24098791 15709043 94281845 80600209 70511209 46225526 139245951 329313172 177955538 968134597 1681847732 1947822946 1853541101 - Rs. MEDICAL as at 336439 1158261 31.03.20 19481021 36440053 71660772 30649060 286295755 129585752 194254332 110656202 370469330 3989926862 3989926862 1513179218 3610454710 1225760667 - - - - Rs. 1158 23166 17880 ASSETS 167009 260089 160518 6645483 1002875 1146249 7283874 1836817 Deletions 29164935 24396799 10619818 276516475 247351540 - - - Rs. 1158 35468 49986 20960 454715 394325 Deletions 9705391 ear 2019-20 During the FIXED 9143104 Y 242414285 252119676 - - - Rs. 23166 17880 as at 210103 167009 160518 6645483 1002875 4937255 1801349 1125289 6829159 1476714 Deletions 24396799 19459544 24002474 31.03.2019 - - Rs. 422899 5179352 4208599 3535178 2019-20 Additions 29963783 10521842 18061128 10896100 65383080 178990995 153069695 631591829 276551880 478522134 151359177 - Rs. GROSS BLOCK 347881 2343761 2662909 7320604 1890504 2222847 56812599 18061128 10896100 63969007 2nd Half Additions 178990995 165015455 398883719 455696319 110177984 - - - Rs. 75018 872269 2835591 1414073 3201239 2318096 1st Half Additions 41181193 27740936 96257096 79638414 111536425 175895510 Rs. aluation 359605 685277 1176141 as at 94281845 32906033 19218640 73765294 113361441 01.04.19 106707692 183899499 306232499 276402530 1053415155 1372439859 3634851509 3358299629 3540569664 Cost V % 5% 20% 15% 20% 15% 15% 10% 10% 20% 30% 20%

AL TIONS TY Y ALLA MARCH, 2018 INST YEAR INCLUDING BOOKS WORK-IN-PROGRESS WORK IN PROGRESS ARE Y & MACHINER - 31ST INCLUDING CAPIT AL AL AL EQUIPMENTS AL OT OT VEHICLE T MESS / CANTEEN EQUIPMENTS OFFICE EQUIPMENTS SOFTW DESCRIPTION LAND LEASEHOLD PROPER BUILDING EQUIPMENTS & INSTRUMENTS PLANT EDP FURNITURE & FIXTURES ELECTRICAL LIBRAR CAPIT T PREVIOUS CAPIT WORK IN PROGRESS 31ST MARCH, 2020 39 MEDICAL RESEARCH FOUNDATION

SCHEDULES TO BALANCE SHEET AS AT 31st MARCH 2020

PARTICULARS AS AT 31.03.2020 AS AT 31.03.2019

Rs. Rs. Rs. Rs. SCHEDULE V

Investments SRTT Corpus 55000000 55000000 Add: Plough back Interest 10834003 65834003 10052186 65052186

MRF Corpus 45000000 45000000 Add: Plough back Interest 9546664 54546664 8926957 53926957

Corpus Fund-PS Foundation 5000000 5000000

SN Mahema Devadoss Endowment Fund 6750000 5060000

Other Corpus Investments 278492742 276097282

Total Investments 410623409 405136425

SCHEDULE VI

CURRENT ASSETS Cash & Bank Balances Cash in Hand 1836162 3429831 Bank Balances - in Savings Account 25789045 55242719 - in Fixed Deposits 945907637 973532844 779031673 837704224

Loans & Advances 49120296 68090080 Deposits 16526351 14769243 Inventories 34402987 23562558 Sundry Debtors 63594952 79069324 TDS Receivable 69819054 77746634 Interest Receivable 15343885 5380637 Prepaid Expenses 15296627 21156401 Total Current Assets 1237636996 1127479101

40 MEDICAL RESEARCH FOUNDATION

SCHEDULES TO INCOME AND EXPENDITURE ACCOUNT

PARTICULARS 31.03.2020 31.03.2019

SCHEDULE - VII Rs. Rs. SALARIES, WAGES & EMPLOYEE BENEFITS Salaries & Wages 650209472 613361970 Contribution to Provident Fund 26966444 28816857 Staff Welfare Expenses 108060631 87005263 Contribution to Superannuation Fund 14566683 13154358 Professional Fees 153133784 142021683 952937014 884360131 SCHEDULE - VIII HOSPITAL EXPENSES Drugs & Consumables 634514162 655392600 Power, Fuel & Water 82457938 82005753 Repairs & Maintenance 183128002 169656577 Insurance 3912248 3968525 Lab Expenses 33469025 32264747 Rent, Rates & Taxes 70513580 71996091 1007994955 1015284293 SCHEDULE - IX ADMINISTRATION EXPENSES Information Techonology Expenses 22691769 21011157 Academic Expenses 59111706 52226180 Communication Expenses 6409301 6899294 Printing & Stationery 11154515 14816328 Vehicle Expenses 12446823 14122994 Security Services 31354778 26287431 Camp Expenses 15992610 14862869 Travelling and Conveyance 4455339 5487289 Books & Periodicals 2960501 3718143 Publicity Expenses 5457294 7286596 Conference 28766801 41865781 Subscription/Membership 3159377 1801289 Function Expenses 1445922 5484060 Legal & Audit Fees 2083319 2321227 Bank Charges 10710936 10476910 Management Consultancy Expenses 1261372 3105541 Miscellaneous Expenses 2103435 2788479 Loss on Sale of Assets 3772318 - 225338116 234561569 SCHEDULE - X INTEREST Interest on ICICI Term Loan 5292444 2228357 5292444 2228357 SCHEDULE - XI INTEREST Research Expenses 14215232 6680394 Orbis Project Expenses 406765 2941 14621997 6683335

41 MEDICAL RESEARCH FOUNDATION

SUB SCHEDULES TO BALANCE SHEET AS AT 31st MARCH 2019

PARTICULARS AS AT 31.03.2020 AS AT 31.03.19 Rs. Rs. Rs. Rs. 1. CASH AND BANK BALANCES

Cash in hand 1836162 3429831 Bank Balances

Andhra Bank 661148 643405 - College Road 966 45855 State Bank of India - PBB 4267406 10761987 State Bank Of India - 671336 2645847 State Bank Of Mauritius -Cathedral Road 394443 1000326 HDFC Bank - Mount Road 133149 128580 HDFC Bank - Nungambakkam 168418 16767121 HDFC Bank - Corpus-Nungambakkam 2209531 2842216 HDFC Bank - Kolkata 1054861 2156399 HDFC Bank - CA-Nungambakkam 598417 2110119 ICICI Bank - Nungambakkam 6375142 871615 Development Credit Bank Ltd - Nungambakkam 1318972 3622583 HDFC Bank - SRTT MRF-Nungambakkam 36515 33093 State Bank Of India - Tada (Sricity) 121016 2095353 IOB-Mahema Devadoss Endowment Fund 11926 953130 City Union Bank - 214087 2402530 IDBI Bank Ltd - Greams Road 46429 44813 State Bank of India - Mukundapur 51112 2790556 Standard Chartered Bank - Parrys 2860155 3148132 HDFC Bank - Nungambakkam - HTPF Project 4147349 97320 HDFC Bank - Nungambakkam - NRTT 446667 25789045 81739 55242719 Fixed Deposits Fixed Deposits 940063738 773187774 Fixed Deposit - Voltas 5843899 5843899 945907637 779031673 973532844 837704224 2. LOANS & ADVANCES Employees' - Loan 9317292 10373987 Advance for Purchases/Contracts 18576535 27623282 Rent Advance 21163869 30055811 Others 62600 49120296 37000 68090080 3. DEPOSITS T.N.E.B 13523647 12852834 Telephone 267753 270114 Others 2734951 16526351 1646296 14769243

42 MEDICAL RESEARCH FOUNDATION

NOTES FORMING PART OF ACCOUNTS FOR THE FINANCIAL YEAR ENDED 31.03.2020 I. ACCOUNTING POLICIES 1. The Foundation follows mercantile system of accounting and recognizes Income and Expenditure on accrual basis.

2. Financial Statements are prepared under historical cost convention.

3. The Fixed Assets of the Foundation are valued at cost less depreciation.

4. Inventories have been valued at Cost.

5. The Foundation’s contribution to various schemes of retirement benefits such as Provident Fund and Superannuation Fund are charged to the Income and Expenditure Account every year.

6. The expenditure on unavailed leave of employees allowed to be encashed by them as per rules of the foundation.

7. Gratuity and Leave Encashment provision have been created on the basis of actuarial valuation.

8. Donation and Grants received towards Capital Purchases are accounted under Capital Fund.

9. Donations received for Community Services accounted under Income Statement.

10. There is an Income tax demand of Rs.9.08 crores for the Assessment year 2015-16 and Rs.16.10 crores for the Assessment year 2016-17 which is pending with the Honorable High Court, Chennai and the provision has not made as on date in the Financial Account.

l The Hon’ble High court Order No.105731 dated 18.12.2019 disposed of the writ petitions filed for the Assessment Year 2015-16 (W.P.No.1293 & 1312 of 2018) with a direction to pass de novo order within six weeks from 07.01.2020.

l As per Income Tax Department, ACIT (Exemptions) Letter No ITBA/COM/F/17/2019- 20/1024352760(1) dated 28.01.2020, the above order would be passed after the receipt of the valuation report u/s. 142A and after affording reasonable opportunities to the assesse as the valuation report sought in respect of Asst. year 2017-18 has a bearing on the de novo assessment order to be passed for Asst. year 2015-16.

43 MEDICAL RESEARCH FOUNDATION

11. There is also a tax demand from the Central excise department for the period from August 2012 to June 2017 for Rs.2.43 crores which is pending with the Commissioner of Appeal I – GST & Central Excise and a Demand and Penalty of Rs.15.69 crores for VAT from the Financial year 2011-12 to Financial Year 2016-17 which is pending with the Honorable High Court, Chennai and the provision has not made as on date in the Financial Accounts.

II. Schedules I to VI of the Balance Sheet and Schedules VII to XI of the Income and Expenditure Account form an integral part of the Balance Sheet. III. Previous year figures have been regrouped wherever necessary to conform to current year’s classification. IV. Impact on COVID-19 – The Hospital was not in operation from 26th March 2020 due to COVID-19 Pandemic. This has marginally affected the functions of the foundation during the Financial Year 2019- 20. V. Statutory Audit fees Rs.1,77,000/- inclusive of GST

RAMACHANDRAN G. DR. GIRISH S. RAO AKILA GANESAN Hony. Secretary & Treasurer President Director - Administration Examined and found correct as per the books maintained by Medical Research Foundation (Regd.) Chennai.

M/S. S. VISWANATHAN, LLP Chartered Accountants 17, Bishop Wallers Avenue (west) Regn, No. 004770S/S200025 C I T Colony, Mylapore, Chennai 4 DATE : 26.09.2020 CHELLA K. SRINIVASAN Partner M.No. 023305

44 MEDICAL RESEARCH FOUNDATION HONOURS & AWARDS l Dr Mona Khurana received the 2019 Outstanding Senior Teaching Assistant in 2019 Principles and Practice of Clinical Research (PPCR) Program from Harvard T H Chan School of Public Health, Boston. l Dr Mamta Agarwal and Dr. Rajiv Raman honoured the Fellowship by the Royal College of Surgeons (Edinburgh). l Dr Pramod Bhende was awarded the “Medical Excellence Award for Ophthalmology” by the World Tamil Chamber of Commerce (WTCC) on the 11th May 2019 at a function held at ‘Le Royal Meridian’ Chennai. He received award from the former Chief Justice and Governor of Kerala, Honourable Shri P.Sathasivam. l The Sri SN Shah Award for equity, was conferred on Sankara Nethralaya in recognition of the significant contribution to preventing and treating childhood blindness by the Elite School of Optometry. Dr Anuradha Narayanan received the award from His Excellency Banwarilal Purohit, the Honorable Governor of Tamil Nadu, at the 15th Vision 2020 Conference held on the 8th June 2019, at Arvind Eye Hospital, Chennai. l Dr. Pramod Bhende delivered Dr. B C Sharma Memorial Oration in Vitreoretinal Sciences on “Pediatric Retinal Detachments” at the 6th Retinal Live 2019 - 6th Retinal Congress and VR Surgical Meet of Jaipur Ophthalmological Society on 16th to 17th June 2019 at Jaipur. l Dr Ekta Rishi and Dr Pukhraj Rishi received the ‘Rhett Buckler Award’ for the Video presentation titled ‘Salvaging an eye with endophthalmatis and permanent Keratoprosthesis’ at the 37th Annual Meeting of the American Society of Retina Specialists (ASRS) held at Chicago, Illinois, from 26th to 30th July 2019. l Larsen & Toubro Technology Services presented an award to Medical Research Foundation in appreciation of continuous engagement and valuable contributions towards fighting rural blindness through Mobile Eye Care and Cataract Surgery at the Annual CSR Partners Meet held at Bangalore on August 01st & 2nd 2019. l “Newsweek”, the international weekly magazine, declared Sankara Nethralaya as one among the ‘Best 4 Ophthalmological Institutions in the World for Year 2020’, based on a survey conducted on a global basis between September and November 2019, by Statista, a leading Research and Analysis organization and Geo Blue a trusted provider of health insurance, especially to international tourists. l Dr Nisar Sonam Poonam, Dr Shebin Salim, Dr Bipasha Mukherjee, and Dr Swatee Halbe received the Best Video Award for the presentation titled “Tackling the Nidus (Embolization and Excision of Orbital AVM)” at the 30th Annual Conference Oculoplastic Association of India (OPAI), held at Guwahati from 6th to 8th September 2019.

45 MEDICAL RESEARCH FOUNDATION l Dr Varsha Backiavathy was the runner up for the presentation on ”Battling a Unique Mold (Orbito-rhino-cerebral aspergillosis)” at the Young Ophthalmologist Oculoplastic Case Competition held at the YOSI session of the 30th Annual conference Oculoplastic Association of India (OPAI). l Dr Bipasha Mukherjee received the Best eposter award in lacrimal session for the poster presentation on “Lacrimal sac Solitary Fibrous Tumor” at the 30th Annual conference Oculoplastic Association of India (OPAI), held at Guwahati from 6th to 8th September 2019. l Dr Nisar Sonam Poonam received the “Best Team: Avengers” in the Oculoplasty Premier League (OPL) for the presentation on “Avenging a Volume Deficient Socket (Autologous Fat Transplant)” at the 30th Annual conference Oculoplastic Association of India (OPAI), held at Guwahati from 6th to 8th September 2019. l Dr Rajiv Raman was conferred with a Doctorate in Health Services by Anglia Ruskin University, Cambridge, UK, , at its Annual Graduation Ceremony held on 14th October 2019. l Dr Rajiv Raman received the P. Siva Reddy International Award at the 78th Annual Conference of All India Ophthalmological Society, AIOC 2020 held in Gurugram, Haryana between 13th and 16th February 2020. l Dr Pukhraj Rishi received Col. Rangachari Award and Best Paper Award for his paper presentation on “Proteomics based approach for differential diagnosis of Age Related Macular Degeneration Subtypes” at the 78th Annual Conference of All India Ophthalmological Society, AIOC 2020 held in Gurugram, Haryana between 13th and 16th February 2020. l Dr Jyotirmay Biswas received the Best Poster Podium Presentation Award for his presentation on “Polymerase Chain Reaction for M. Tuberculosis Positive Intermediate Uveitis – Analysis of 13 Cases” at the 78th Annual Conference of All India Ophthalmological Society, AIOC 2020 held in Gurugram, Haryana between 13th and 16th February 2020. l The Senior Citizens Group of Besant Nagar, Chennai, honoured Dr. S S Badrinath with the Most Admired Gandhian of Tamil Nadu Award on 1st November 2019. l Dr. Ronnie George was honoured the Dr Noel Moniz Oration Award in the 46th Annual Conference of Kerala Society of Ophthalmic Surgeons held from 22nd to 24th Nov 2019 at Lulu international Conventional Centre, Thrissur. l Sankara Nethralaya was chosen as the ‘Best Healthcare Institution’ at the D2d (Dare to Dream Awards- Season-2) organized jointly by Zee Business and SAP, India. Dr Girish Shiva Rao, President & Medical Director, MRF received the ‘Zee Dare to Dream’ Award-2019 from Dr Rajendra Kumar, Principal Secretary & Industries Commissioner, Government of Tamil Nadu; Mr Ritwik Ray, Senior Sales Manager, SAP, India and Mr Lal Singh, General Manager, Union Bank Of India, Chennai at the award ceremony held at the Regency, Chennai on 1st December 2019.

46 MEDICAL RESEARCH FOUNDATION l Dr. Ekta Rishi received the Best Video Award for the presentation of “Salvaging an eye with Endophthalmitis and Permanent Keratoprosthesis at the 28th Annual Conference of Vitreo Retinal Socieity – India, held at Lucknow from 5th to 8th December 2019. l Dr P P Santanam was honoured with the “Dr. C K Ramchander Life Time Achievement Award” by Indian Association of Occupational Health (IAOH), at the 70th National Conference of Indian Association of Occupational Health held at Nehru Center, Mumbai on 29th January 2020. l Dr. T. S. Surendran was conferred with the “Lifetime Achievement Award” by the International Association of Lions Club Dt. 324 A1, Region IV on 1st February 2020. l Dr.Rizwana Husaindeen has been appointed as the ‘President of the American Academy of Optometry (AAO) India Chapter on 24th February 2020. l Dr V V Jaichandran attended the 5th World Congress of Ophthalmic Anesthesia (WCOA), held at Jakarta, Indonesia on 7th and 8th February 2020. His E-Poster titled ‘Mannequin Based Training of Regional Ophthalmic Anaesthesia’ received the 1st Runner-up Prize Award. l Dr V V Jaichandran elected as the International President for World Congress of Ophthalmic Anaesthesia, WCOA, for the years 2020-2024. l Sankara Nethralaya celebrated 80th Birthday of its beloved Chief Dr. S S. Badrinath on 24th February 2020. On this special occasion, 100 cost free cataract surgeries were performed on indigent patients as a befitting tribute and birthday gift to its Founder and Chairman Emeritus Dr S S Badrinath. l Dr. Ronnie George has been elected as the Section Editor of Indian Journal of Ophthalmology; Member of the Editorial Board in the Journal of Glaucoma, and Journal of Tamil Nadu Ophthalmic Association. l Dr. Rajiv Raman has been elected as a Member, AIOS National Taskforce for Diabetic Retinopathy – 2019, Member of Speciality Board of National Board of Examination, Government of India 2019. l Dr. Rajiv Raman appointed as the Grant Reviewer for Swiss National Science Foundation and Diabetes UK. l Dr. S Meenakshi has been elected as a member of the Editorial Board of Indian Journal of Ophthalmology for Paediatric Ophthalmology and Centre for Ophthalmic Educators of the International Council of Ophthalmology. l Dr Mamta Agarwal has been elected as the Reviewing Editor of the Journal of Ocular Immunology and Inflammation. l Dr Dhanashree Ratra has been selected as the Section Editor for Surgical Retina in the Indian Journal of Ophthalmology. l Dr Dhanashree Ratra received an award for Best Research at the International Conference of the Women's Ophthalmologic Society held at Bangalore in September 2019. l Dr. Anuradha was conferred with the Fellowship of American Academy of Optometry.

47 MEDICAL RESEARCH FOUNDATION

RESEARCH PUBLICATIONS INTERNATIONAL JOURNALS : l Rajasekaran, S., Nagarajha Selvan, L.D., Dotts, K., Kumar, R., Rishi, P., Khetan, V., Bisht, M., Sivaraman, K., Krishnakumar, S., Sahoo, D. and Campbell, M.J., 2019. “Non-coding and coding transcriptional profiles are significantly altered in pediatric retinoblastoma tumors” Frontiers in oncology, April 9, p.221 l Vinita Girish Rao, M.K. Janani, Jyotirmay Biswas “Real-time polymerase chain reaction in recurrent cytomegalovirus anterior uveitis”, Am J Ophthalmol Case Rep. 2019 May 20; 15:100470. l Karthikka Palanisamy, Coral Karunakaran, Rajiv Raman, Subbulakshmi Chidambaram. “Optimization of an in vitro bilayer model for studying the functional interplay between human primary retinal pigment epithelial and choroidalendothelial cells isolated from donor eyes”. BMC Res Notes, May ,2019. l Kannadasan Anand Babu, Parveen Sen, Narayanasamy Angayarkanni. “Oxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro- oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells” PlosOne, May, 2019 l Gulshan V, Rajan RP, Widner K, Wu D, Wubbels P, Rhodes T, Whitehouse K, Coram M, Corrado G, Ramasamy K, Raman R, Peng L, Webster DR. “Performance of a Deep-Learning Algorithm vs Manual Grading for Detecting Diabetic Retinopathy in India” JAMA Ophthalmol. 2019 Jun 13;137(9):987-93. l Dutta Majumder P, Mistry S, Luthra S, Shrutanjoy M Das, Sekar V, Rishi E, Biswas J. “Atypical posterior pole retinitis” Am J Ophthalmol Case Rep. 2019 Jun 13;15:100494. l Rishi P, Multani P, Prasan VV, Rishi E, Attiku Y. “Choroidal thickness in Waardenburg syndrome” GMS Ophthalmol Cases. 2019 Jun 18;9: Doc 22. l Kulandhai LT, Bhagavathi H, Krishnan S, Krishnan K, Balasubramaniyam M, Madhavan HN. “Seroprevalence of Anti-HIV-1, Anti-HIV-2, Hepatitis B Surface Antigen, and Anti-HCV in Eye Donors in a Tertiary Eye Hospital, Chennai, India, in the Past 13 years (2005-2017)”, Cornea. 2019 Jun;38(6):737-741. l Choudhari NS, Richhariya A, Wadke V, Deshmukh SP, George R, Senthil S, Chandra Sekhar G. “The Outcomes of a Comprehensive Program for Maintenance of Goldmann Applanation Tonometer” J Glaucoma. 2019 Jun;28(6):507-511. l Meethal NS, Pel JJ, Mazumdar D, Asokan R, Panday M, van der Steen J, George R. “Eye Movement Perimetry and Frequency Doubling Perimetry: clinical performance and patient preference during glaucoma screening” Graefe's Archive for Clinical and Experimental Ophthalmology. 2019 Jun 4;257(6):1277-87.

48 MEDICAL RESEARCH FOUNDATION l Sudhir RR, Dey A, Bhattacharrya S, Bahulayan A. “AcrySof IQ PanOptix Intraocular Lens Versus Extended Depth of Focus Intraocular Lens and Trifocal Intraocular Lens: A Clinical Overview” Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):335-349. l Srinivasan S, Raman R, Kulothungan V, Pal SS, Roy R, Ganesan S, Sharma T. “Four-year Incident Neuropathy and its Risk Factors in Subjects with Type 2 Diabetes” J Assoc Physicians India. 2019 Jul;67(7):34-37. l Wadke V, Lingam V, George R, George AE, Ganesh SK, Biswas J, Balekudaru S. “Phacotrabeculectomy in Eyes with Uveitic Glaucoma: A Retrospective Case-Control Study” J Glaucoma. 2019 Jul;28(7):606-612. l Ruamviboonsuk P, Krause J, Chotcomwongse P, Sayres R, Raman R, Widner K, Campana BJL, Phene S, Hemarat K, Tadarati M, Silpa-Archa S, Limwattanayingyong J, Rao C, Kuruvilla O, Jung J, Tan J, Orprayoon S, Kangwanwongpaisan C, Sukumalpaiboon R, Luengchaichawang C, Fuangkaew J, Kongsap P, Chualinpha L, Saree S, Kawinpanitan S, Mitvongsa K, Lawanasakol S, Thepchatri C, Wongpichedchai L, Corrado GS, Peng L, Webster DR. “Erratum: Author Correction: Deep learning versus human graders for classifying diabetic retinopathy severity in a nationwide screening program” NPJ Digit Med. 2019 Jul 23;2:68. l Deepmala Mazumder, Najiya S Kadavath Meethal Manish Pandey, Rashima Asokan. “Effect of Age, Sex Stimulus Intensity, and Eccentricity on Saccadic Reaction Time in Eye Movement Perimetry”. Transl Vis Sci Technol. 2019 Jul; 8(4): 13. l Rupak Roy, Kumar Saurabh, Dhaivat Shah, Maitreyi Chowdhury, Sugandha Goel. “Choroidal Hyperreflective Foci: A Novel Spectral Domain Optical Coherence Tomography Biomarker in Eyes with Diabetic Macular Edema” Asia Pac J Ophthalmol (Phila) Jul-Aug 2019;8(4):314-318. l Singh N, Jain M, Jaisankar D, Sharma T, Raman R Sankara Nethralaya Vitreoretinal Study Group (SNVR-Study Group). “Bilateral Simultaneous Rhegmatogenous Retinal Detachment: Clinical Characteristics and Surgical Outcome” Retina. 2019 Aug; 39(8):1504-1509. l John S, Srinivasan S, Raman R, Ram K, Sivaprakasam M. “Validation of a Customized Algorithm for the Detection of Diabetic Retinopathy from Single-Field Fundus Photographs in a Tertiary Eye Care Hospital” Stud Health Technol Inform. 2019 Aug 21;264:1504-1505. l Nikhalashree S, George R, Shantha B, Lingam V, Vidya W, Panday M, Sulochana KN, Coral K. “Detection of Proteins Associated with Extracellular Matrix Regulation in the Aqueous Humour of Patients with Primary Glaucoma” Curr Eye Res. 2019 Sep;44(9):1018-1025. l Aberami S, Nikhalashree S, Bharathselvi M, Biswas J, Sulochana KN, Coral K. “Elemental concentrations in Choroid-RPE and retina of human eyes with age-related macular degeneration”. Exp Eye Res, Sep 2019. l Ganesh SK, Abraham S, Sudharshan S. “Paradoxical reactions in ocular tuberculosis” J Ophthalmic Inflamm Infect. 2019 Sep 6;9(1):19. l Saurabh K, Roy R, Thomas NR. ”Multicolor Imaging Characteristics of Best's Vitelliform Macular Dystrophy” Middle East Afr J Ophthalmol. 2019 Sep 30;26(3):178-180.

49 MEDICAL RESEARCH FOUNDATION l Wong W, Sundar G, Chee C, Zhao PS, Rajagopalan R, Gopal L. “Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre” Singapore Med J. 2019 Sep;60(9): 474- 478. l Alam MS, Jain M, Mukherjee B, Sharma T, Halbe S, Jaisankar D, Raman R. ”Visual impairment in high flow and low flow carotid cavernous fistula” Sci Rep. 2019 Sep 6;9(1):12872. l Rishi P, Majumder PD, Biswas J. “Anterior Chamber Migration of Fluocinolone Acetonide Intravitreal Implant” JAMA Ophthalmol. 2019 Sep 1;137(9):e185931. l Rishi P, Sharma U, Sharma T. “Cavitary retinoblastoma: clinical observations” Eye (Lond). 34(4):704-710. Epub 2019 Sep 18. l Kuppan K, Mohanlal J, Mohammad AM, Babu KA, Sen P, Undurti ND, Natarajan V, Narayanasamy Angayarkanni. “Elevated Serum OxLDL is associated with progression of type 2 Diabetes Mellitus to Diabetic Retinopathy” Exp Eye Res. Sep 2019. l Gopakumar V, Agarwal S, Srinivasan B, Krishnakumar S, Krishnan UM, Iyer G. ”Clinical Outcome of Autologous Cultivated Oral Mucosal Epithelial Transplantation in Ocular Surface Reconstruction” Cornea 2019 Oct;38(10):1273-1279. l Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P. “Retinopathy of prematurity treatment: Asian perspectives” Eye (Lond) 2020 34(4):632-642. Epub 2019 Oct 29. l Dutta Majumder P, Shah A, Madhuravasal Krishnan J, Rishi E. “Driving in Fog without Headlight: Management of a Challenging Case of Presumed Ocular Toxoplasmosis” Curi ALL. Ocul Immunol Inflamm. 2019 Oct 2:1-3. l Reddy AVC, Mani R, Selvakumar A, Hussaindeen JR “Reading eye movements in traumatic brain injury” J. Optom. 2019 Nov 26:S1888-4296(19)30102-5. l Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, McCluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Rousselot A, Grant R, Kon OM, Cunningham ET, Kempen J, Nguyen QD, Pavesio C, Gupta V. “Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1Testi I” Ocul Immunol Inflamm. 2019 Nov 25:1-9. l Barh A, Mukherjee B, Koka K, Krishnakumar S. “Triton tumor of the orbit”, Orbit. 2019 Nov 20:1- 4. l Shah A, Rajesh PS, Dutta Majumder P. “Iris cyst following cataract surgery” Clin Exp Optom. 2019 Nov 14. l Singh S, Neriyanuri S, Raman R. “Management of macular edema with branch retinal vein occlusion in a case of secondary polycythemia” GMS Ophthalmol Cases. 2019 Nov 20;9:Doc38.

50 MEDICAL RESEARCH FOUNDATION l Sampath NikhalaShree, Gayathree Karthikkeyan, Ronnie George, BalekudaruShantha, Lingam Vijaya, Vineet Ratra, Konerirajapuram Natarajan Sulochana, Karunakaran Coral. “Lowered Decorin With Aberrant Extracellular Matrix Remodeling in Aqueous Humor and Tenon's Tissue From Primary Glaucoma Patients” Invest Ophthalmol Vis Sci, Nov, 2019. l Sen P, Abraham S, Jain S, Gopal L, Bhende P. “Treatment outcomes of zone 1 retinopathy of prematurity: A study from a tertiary eye care center in ” Taiwan J Ophthalmol. 2019 Dec 13;9(4):255-261. l Choudhari NS, George R, Asokan R, Khanna R, Vijaya L, Garudadri CS. “Combination of Simple Diagnostic Tests to Detect Primary Angle Closure Disease in a Resource-constrained Region” Ophthalmic Epidemiol. 2019 Dec;26(6):430-438. l Agrawal R, Agarwal A, Jabs DA, Kee A, Testi I, Mahajan S, McCluskey PJ, Gupta A, Palestine A, Denniston A, Banker A, Invernizzi A, Fonollosa A, Sharma A, Kumar A, Curi A, Okada A, Schlaen A, Heiligenhaus A, Kumar A, Gurbaxani A, Bodaghi B, Islam Shah B, Lowder C, Tappeiner C, Muccioli C, Vasconcelos-Santos DV, Goldstein D, Behra D, Das D, Makhoul D, Baglivo E, Denisova E, Miserocchi E, Carreno E, Asyari F, Pichi F, Sen HN, Uy H, Nascimento H, Tugal-Tutkun I, Arevalo JF, Davis J, Thorne J, Hisae Yamamoto J, Smith J, Garweg JG, Biswas J, Babu K, Aggarwal K, Cimino L, Kuffova L, Agarwal M, Zierhut M, Agarwal M, De Smet M, Tognon MS, Errera MH, Munk M, Westcott M, Soheilian M, Accorinti M, Khairallah M, Nguyen M, Kon OM, Mahendradas P, Yang P, Neri P, Ozdal P, Amer R, Lee R, Distia Nora R, Chhabra R, Belfort R, Mehta S, Shoughy S, Luthra S, Mohamed SO, Chee SP, Basu S, Teoh S, Ganesh S, Barisani-Asenbauer T, Guex-Crosier Y, Ozyazgan Y, Akova Y, Habot-Wilner Z, Kempen J, Nguyen QD, Pavesio C, Gupta V; , “Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop Collaborative Ocular Tuberculosis Study (COTS) Group.” Ocul Immunol Inflamm. 2019 Dec 10:1-11. l Goel S, Saurabh K, Roy R. “Multicolour imaging in retinochoroidal coloboma” , Clin Exp Optom. 2019 Dec 5. l Anuradha Narayanan, Mohan Venkadesan, Sruthisree Krishnamurthy, Jameel R Hussaindeen, Krishna Kumar Ramani. “Dalton’s pseudo-isochromatic plates and congenital colour vision deficiency.” Clin Exp Optometry: 2019; Dec; 1-5 l Singh P, Madhuravasal Krishnan J, Kumar A, Roy R, Biswas J. ”Cladosporium Endogenous Endophthalmitis Mimicking Toxoplasma Retinochoroiditis” Ocul Immunol Inflamm. 2019 Dec 11:1-2. l Khurana M, Alam MS, Balekudaru S, Vijaya L, Madhuri MB, Halbe SV, Noronha VO, George RJ, Mukherjee BJ, “Intraocular Pressure in the Eyes of Patients With Carotid-Cavernous Fistulas: Profile, Intereye Asymmetry, and Treatment Outcomes Glaucoma” Journal of Glaucoma 2019 Dec;28(12):1074-1078. l Rishi P, Trivedi M, Sreelakshmi K. “Choroidal Nevus and Melanoma in Patients with Oculocutaneous Albinism” Ocul Oncol Pathol. 2020 Jan;6(1):31-34.

51 MEDICAL RESEARCH FOUNDATION l Najiya Sundus, Velumuri Lokapavani, Rashima Asokan, Lingam Vijaya, Ronnie George. “SITA Standard testing with Humphrey Visual field analyser versus full threshold testing with frequency doubling perimetry: a comparison of patient preference and perception”. Asian Journal of Ophthalmology, January 2020. l Naik AU, Raman R. “Bilateral Choroidal Osteomas with Choroidal Neovascularization” JAMA Ophthalmol. 2020 Jan 1;138(1):e190059. l Sen P, Singh N, Rishi E, Bhende P, Rao C, Rishi P, Bhende M, Sharma T, Gopal L. “Outcomes of surgery in eyes with familial exudative vitreoretinopathyassociated retinal detachment” Can J Ophthalmol. E-pub 2020 Jan 13:S0008-4182(19)30953-6. l Jaisankar D, Kumar M, Rishi P, Singh S, Raman R. “Correlation of retinal changes with choroidal changes in acute and recurrent central serous chorioretinopathy assessed by swept-source optical coherence tomography” Ther Adv Ophthalmol. 2020 Jan 20;12:2515841419899823. l Verma A, Alagorie AR, Ramasamy K, van Hemert J, Yadav NK, Pappuru RR, Tufail A, Nittala MG, Sadda SR, Raman R Indian Retina Research Associates (IRRA). “Distribution of peripheral lesions identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy” Graefes Arch Clin Exp Ophthalmol. Epub 2020 Jan 27.258(4):725-733. l Shah A, Biswas J. “Cytopathology and Polymerase Chain Reaction of Vitreous Fluid in Tubercular Intermediate Uveitis”, Ocul Immunol Inflamm. 2020 Jan 6:1-3. l Varuna Kumaran, Krishna Kumar, Naveen Mahesh, B.E. “Application of an Online Homework Tool in Optometry for Geometric Optics Improves Exam Performance”. Optometric Education: 2020. l Ayisha Atiya, Jameel Rizwana Hussaindeen, Supraja Kasturirangan, Srikanth Ramasubramanian, K Swathi Meenakshi Swaminathan. “Frequensy of undetected binocular vision anomalies among ophthalmology trainees”. Journal of Optometry: Jan 2020; 1-8. l Mazumdar D, Lal B, Asokan R. “Anterior segment optical coherence tomography of intrastromal corneal cysts”. Asian Journal of Ophthalmology. Jan 2020;17(1):41-4. l Dalan D, Jaisankar D, Mani K, Madhu A, Ratra D. “A multifocal electroretinography study to evaluate risk of developing macular hole in the fellow eye of patients suffering with unilateral macular hole” Ther Adv Ophthalmol. 2020 Feb 26;12:2515841420908697. l Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A, Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaly U, Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al- Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R, Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam J, Calderón-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G,

52 MEDICAL RESEARCH FOUNDATION

Castillo L, Català -Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B, Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcroft RL, Comsa C, Correa ZM, Correa Llano MG, Corson TW, Cowan-Lyn KE, Csóka M, Cui X, Da Gama IV, et a , “Global Retinoblastoma Presentation and Analysis by National Income Level” Global Retinoblastoma Study Group, Fabian ID JAMA Oncol. 2020 Feb 27;6(5):1-12. l Zakir SM, Alam MS, Askari SN, Imran M. “Pattern of ocular morbidity among students in a school for visually impaired children in North India” Oman J Ophthalmol. 2020 Feb 17;13(1):24-28. l Ravishankar H, Mangani AS, Shankar MB, Joshi M, Devasena T, Parameswaran S, Subramaniam K “Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site” Histochem Cell Biol. 2020 Feb;153(2):101-109. l Sen P, Attiku Y, Bhende P, Rishi E, Ratra D, Sreelakshmi K. “Outcome of sutured scleral fixated intraocular lens in Marfan syndrome in pediatric eyes” Int Ophthalmol. 2020 Feb 28. l Lakra R, Shah A, Kaushik V, Biswas J, Dutta Majumder P. “Use of Anti-Tumour Necrosis Factor- Alpha Agents in the Management of HLA-B-27-Associated Uveitis: The First Case Series from India” Ocul Immunol Inflamm. 2020 Feb 14:1-5. l Agarkar S, Koladiya N, Kumar M, Vijaya L, Raman R. “Nanophthalmos in children: morphometric and clinical characterization” J AAPOS. 2020 Feb;24(1):27.e1-27.e5. l Khurana M, Shah DD, George RJ, Vijaya L, Balekudaru S. “Phacoemulsification in eyes with long anterior zonules” J Cataract Refract Surg 2020 Feb;46(2):209-214. l Agarwal S, Majumder PD. “Pseudomonas aeruginosa scleritis initially presenting as idiopathic diffuse anterior scleritis” Oman J Ophthalmol. 2020 Feb 17;13(1):51-52. l Radosavljevic A, Agarwal M, Bodaghi B, Smith JR, Zierhut M. “Medical Therapy of Uveitic Macular Edema: Biologic Agents” Ocul Immunol Inflamm. 2020 Feb 14:1-12. l Sen P, Sudharshan S, Banerjee A, Dhami A. “Clinical and electrophysiological characteristics of Efavirenz-induced macular toxicity” GMS Ophthalmol Cases. 2020 Feb 27;10:Doc08. l Philip R, Balekudaru S, Vijaya L, George R. “Intraocular Pressure Outcomes after Surgery for Rhegmatogenous Retinal Detachment in Schwartz Syndrome” Retina. 2020 Feb 7. l Dhami A, Shah KK, Anshuman K, Ratra D. “Correspondence“ Retina. 2020 Mar; 40(3):e11. l Gopalakrishnan S, Jacob CES, Kumar M, Karunakaran V, Raman R. Hyungtaek Rim T, Ryo K, Tham YC, Kang SW, Ruamviboonsuk P, Bikbov MM, Miyake M, Hao J, Fletcher A, Sasaki M, Nangia V, Sabanayagam C, Yu M, Fujiwara K, Thapa R, Wong IY, Kayama T, Chen SJ, Kuang TM, Yamashita H, Sundaresan P, Chan JC, van Rens GHMB, Sonoda KH, Wang YX, Panda-Jonas S, Harada S, Kim R, Ganesan S, Raman R, Yamashiro K, Gilmanshin TR, Jenchitr W, Park KH, Gemmy Cheung CM, Wong TY, Wang N, Jonas JB, Chakravarthy U, Cheng CY, Yanagi Y, Saenmee A, Cao K, George R, Kazakbaeva GM, Khalimov TA, Khanna RC, Kim HW, Kulothungan V, Nangia P, Mao F, Matsuda F, Meng Q, Namba H, Pokawattana N, Oh J, Park SJ, Ravindran R, Sharma T, Shin JP, Surya J, Takahashi A, Takebayashi T, Tsujikawa A, Vashist P, Wei WB, Yang X, Yu SY, Zainullin RM, Zhao PQ. “Comparison of Visual Parameters between Normal Individuals and People with Low Vision in a Virtual Environment” Cyberpsychol Behav Soc Netw. 2020 Mar;23(3):171-178.

53 MEDICAL RESEARCH FOUNDATION l Alagappan LP, Koh JEW, V J, Ramesh A, Bhende M, Raman R, Acharya UR, Mathavan S. “Development of an automated system for the detection of genotype in polypoidal choroidal vasculopathy using retinal image phenotype” Comput Methods Programs Biomed. Epub 2020 Mar 19. l Kumar M, van Dijk EHC, Raman R, Mehta P, Boon CJF, Goud A, Bharani S, Chhablani J. “Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy” BMC Ophthalmol. 2020 Mar 6;20(1):90. l Asia Ruamviboonsuk P, Cheung CY, Zhang X, Raman R, Park SJ, Ting DSW. “Artificial Intelligence in Ophthalmology: Evolutions” Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr;9(2):78-84.. l Alam MS, Vijay V, Barh A, Subramanian K. “Plasma cell granuloma of the conjunctiva in a young female” Orbit. 2020 Mar 1:1-4. l Rahman Z, Jafarullah O, Huq N, Hasan K, Magesan K, Dutta Majumder P. “Clinical Profile of Patients with Scleritis in Bangladesh” Ocul Immunol Inflamm. 2020 Mar 4:1-4. l Gupta P, Pradeep S, Biswas J, Rishi P, Muthusamy R. ”Extensive Chorio-retinal Damage Due to Dirofilaria Repens- Report of a Case” Ocul Immunol Inflamm. 2020 Mar 11:1-3. l Iyer G, Srinivasan B, Agarwal S, Subramanian K. “Ectopic sebaceous glands of Gibsan in eyelid margin- A novel manifestation in Stevens Johnson Syndrome & proposed nomenclature based on an observational case series” Ocul Surf. Epub 2020 Mar 16: S1542-0124(20) 30056-2. NATIONAL JOURNALS : l Gopalakrishnan Sarika, Dinesh Venugopal, M V S Sailaja, Sheela Evangeline, Ramani K Kumar. Barriers and enablers to low vision care services in a tertiary eye care hospital: A Mixed Method Study. Indian J Ophthalmol. 2019 April; Vol 67, Issue 4 , 536-540 l Rishi P, Singh N, Rishi E.“Retinopathy in incontinentia pigmenti” Indian J Ophthalmol. 2019 May; 67(6):940-942. l Aditya Maitray, Ekta Rishi, Pukhraj Rishi, Lingam Gopal, Pramod Bhende, Rupak Ray, Kuzhanthai Lily Therese. “Endogenous endophthalmitis in children and adolescents: Case series and literature review” Indian J Ophthalmol. 2019 Jun;67(6):795-800. l Naik AU, Rishi E, Rishi P. “Pediatric vitreous hemorrhage: A narrative review” Indian J Ophthalmol. 2019 Jun;67(6):732-739. l Sharma N, Arora T, Singhal D, Maharana PK, Garg P, Nagpal R, Murthy S, Gunnam S, Arora A, Prajna V, Rajaraman R, Padmanabhan P, Kumar A, Kumar R, Tomar S, Thomas A, Gyanchand R, Arora R, Biswas B, Basak S. “Procurement, storage and utilization trends of eye banks in India” Indian J phthalmol. 2019 Jun;67(7):1056-1059. l Shah KK, Rishi E, Bhende P, Rishi P, Sharma T. “To remove the buckle or watch?” Indian J Ophthalmol. 2019 Jun;67(6):973-974.

54 MEDICAL RESEARCH FOUNDATION l Sen P, Agarwal A, Bhende P, Gopal L. “Surgical outcomes of vitreoretinal surgery for rhegmatogenous retinal detachment in eyes with regressed retinopathy of prematurity” Indian J Ophthalmol. 2019 Jun;67(6):896-902. l Rishi E, Srinivasan B, Singh N, Gopal L. “Late onset Descemet's membrane detachment: 15 years after limbal lensectomy with vitrectomy for ROP” Indian J Ophthalmol. 2019 Jun;67(6):965-966. l Sen P, Bhende P, Sharma T, Gopal L, Maitray A, Shah P, Oke Y. “Surgical outcomes of microincision vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in Indian population” Indian J Ophthalmol. 2019 Jun;67(6):889-895. l Goel S, Das D, Saurabh K, Roy R. “Multicolour imaging in retinal astrocytoma” Indian J Ophthalmol. 2019 Jul;67(7):1167-1168. l Das D, Boddepalli A, Biswas J.”Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease” Indian J Ophthalmol. 2019 Jul;67(7):1217-1219. l Lakshmipathy M, Susvar P, Popet K, Rajagopal R. “Subconjunctival bevacizumab and argon laser photocoagulation for preexisting neovascularization following deep lamellar anterior keratoplasty” Indian J Ophthalmol. 2019 Jul;67(7):1193-1194. l Ratra D, Yadav H, Dalan D, Sodhi PKS, Ratra V. ”Retinal vascular abnormalities in Sturge-Weber syndrome” Indian J Ophthalmol. 2019 Jul;67(7):1223-1226. l Anshuman K, Ramesh V, Dalan D, Ratra D. “Ophthalmic artery occlusion following blunt trauma” Indian J Ophthalmol. 2019 Jul;67(7):1183 l Alam MS, Tongbram A, Krishnakumar S, Mukherjee B. “Ciliochoroidal melanoma presenting as bleeding anterior staphyloma: Report of a case and review of literature” Indian J Ophthalmol. 2019 Jul;67(7):1162-1163. l Anshuman K, Ratra D. “Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy” Indian J Ophthalmol. 2019 Jul;67(7):1119-1120. l Majumder AK, Sheth S, Dharani V, Dutta Majumder P. “An unusual case of tuberculous optic neuropathy associated with choroiditis” Indian J Ophthalmol. 2019 Jul;67(7):1210-1212. l Agarwal AM, Dutta Majumder P. “Tubercular posterior scleritis: A case report and review of literature” Indian J Ophthalmol. 2019 Aug;67(8):1362-1365. l Dutta Majumder P; Jayshree, David RL, Kaushik V. “A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation” Indian J Ophthalmol. 2019 Aug;67(8):1360-1362. l Biswas J “Commentary: Seeing a worm in the eye - Is it enough?” Indian J Ophthalmol. 2019 Sep;67(9):1492-1493.

55 MEDICAL RESEARCH FOUNDATION l Dutta Majumder P, Mayilvakanam L, Palker AH, Sridharan S, Biswas J. ”Intravitreal sustained- release dexamethasone implant for the treatment of persistent cystoid macular edema in ocular syphilis“ Indian J Ophthalmol. 2019 Sep;67(9):1487-1490. l Subramaniam Rajesh Bharathi Devi, Karunakaran Coral, Karthikeyan Gayathree, Muthuvel Bharathselvi, Shanmuganathan Sivasankar, Jyotirmoy Biswas, Pukhraj Rishi, Sundaram Natarajan, Sengamedu Srinivasa Badrinath, Narayanasamy Angayarkanni. “Case report on two diabetic donor eyes with no retinopathy: Clinicopathological and molecular studies” Indian Journal of Ophthalmology, September 2019. l Roy R, Saurabh K, Shah D, Goel S. “Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor” Indian J Ophthalmol. 2019 Oct;67(10):1678-1683. l Schouten IM, Palkar AH, Bhende M. “Macular vortex vein with choroidal neovascularisation in pathologic myopia” Indian J Ophthalmol. 2019 Oct;67(10):1717-1718. l Latiff N, Sudharshan S, Verma A, Khetan V, Biswas J. “Iridocilary tuberculoma mimicking melanoma” Indian J Ophthalmol. 2019 Nov;67(12):2048-2049. l Mukherjee B, Moosa S, Rajagopal R. “Cavernous hemangioma of the conjunctiva“ Indian J Ophthalmol. 2019 Nov;67(12):2061. l Gudkar AI, Mukherjee B, Krishnakumar S. “Solitary Fibrous Tumor of the lacrimal sac“ Indian J Ophthalmol. 2019 Nov; 67(12):2043-2044. l Biswas J. “Commentary: As is our pathology, so is our practice” Indian J Ophthalmol. 2019 Dec; 67(12):1996. l Attiku Y, Khetan V.”Commentary: Prognostication of uveal melanoma based on molecular diagnosis - Are we there yet?” Indian J Ophthalmol. 2019 Nov; 67(12):1964. l Alam MS, Tongbram A, Krishnakumar S, Biswas J, Mukherjee B. “Sensitivity and specificity of frozen section diagnosis in orbital and adnexal malignancies” Indian J Ophthalmol. 2019 Dec;67(12):1988-1992. l Das D, Krishnakumar S, Biswas J. “Sympathetic ophthalmia with incidental finding of chicken pox supported by histopathology and immunohistochemistry” Indian J Pathol Microbiol. 2019 Oct-Dec;62(4):592-594. l Shah A, Rao C, Kumar K, George RJ, Dutta Majumder P. “Inflammatory deposits on the foldable intraocular lens” Indian J Ophthalmol. 2020 Jan;68(1):190-191. l Badrinath SS, Narayanan A, Hussaindeen JR, Surendran TS. “The Sankara Nethralaya Community model - Technology and evidence based comprehensive quality eye care equally to all” Indian J Ophthalmol. 2020 Feb;68(2):288-290. l Rijey J, Goel S, Saurabh K, Roy R. ”A rare case of ruptured optic disc retinal arterial macroaneurysm and its successful management with intravitreal ranibizumab” Indian J Ophthalmol. 2020 Jan;68(1):200-201.

56 MEDICAL RESEARCH FOUNDATION l Dutta Majumder P, Menia N, Sudharshan S, Rao C, Ganesh SK, Biswas J. “Response to comments on: Clinical profile of uveitis patients developing central serous chorioretinopathy - An experience at a tertiary eye care center in India” Indian J Ophthalmol. 2020 Jan;68(1):269-270. l Bhende PS. “Retinopathy of prematurity” Indian J Ophthalmol. 2020 Feb; 68 (Suppl 1):S10-S11. l Dutta Majumder P. “Commentary: Tick talk: A glimpse into the literature“ Indian J Ophthalmol. 2020 Jan;68(1):104-105. l Madanagopalan VG, Raman R. “Commentary: Artificial intelligence and smartphone fundus photography - Are we at the cusp of revolutionary changes in retinal disease detection?” Indian J Ophthalmol. 2020 Feb;68(2):396-397. l Jain S, Raman R. “Autofluorescence in scleral buckle intrusion” Indian J Ophthalmol. 2020 Mar;68(3):527. l Kunal K Shah and Pramod S Bhende. “Swiss-cheese macula” Indian J Ophthalmol. 2020 Mar; 68(3): 526. l Dalan D, Nandini P, Angayarkanni N, Kaviarasan K, Thanikachalam S, Das UN, Ratra D. “Interchangeability of retinal perfusion indices in different-sized angiocubes: An optical coherence tomography angiography study in diabetic retinopathy” Indian J Ophthalmol. 2020 Mar;68(3):484-489. l Bassi ST. “Commentary: Viewing Alzheimer's disease from an ophthalmologist's eyes” Indian J Ophthalmol. Epub 2020 Mar 16;68(4):562-563. l Dutta Majumder P, Koka K, Noronha V. “An unusual case of orbital myositis in a patient with HLA B-27-associated uveitis” Indian J Ophthalmol. Epub Mar 2020. l Das D, Biswas J, Bhattacharjee H. “Commentary: Pattern of uveitis in a tertiary eye care center of central India: Results of a prospective patient database over a period of two years” Indian J Ophthalmol. 2020 Mar;68(3):482-483.

57 MEDICAL RESEARCH FOUNDATION

COMPLETED PROJECTS: l Protocol No. ILD432-P001 An Observational, Prospective, Post-Marketing Clinical Study of the ACRYSOF® IQ PanQptix Multifocal IOL in an Indian Population. [Dr Prema Padmanabhan] l Knowledge and Attitude about Colour Vision Deficiency among stakeholders of school eye screening- A qualitative study [Dr Anuradha N] l Profile of Binocular Vision function in patients with Keratoconus [Dr Prema Padmanabhan] l Measurement of Aqueous Flare: Comparison between Kowa FM 700 Laser Flare Meter and Spot fluorometer [Principal Investigator : Dr. Prema Padmanabhan] l Persistent Low grade inflammation following Corneal Transplantation – a possible cause for enhanced endothelial attrition [Principal Investigator : Dr. Prema Padmanabhan] l Neurotrophins and inflammatory markers in the progression of pre-diabetes to Type II Diabetes Mellitus and Diabetic Retinopathy [Dr Dhanashree Ratra] l Visual Rehabilitation using video game stimulation and teleophthalmology- a pilot study [Dr Dhanashree Ratra] l A system for measurement of amblyopia and strabismus – specific quality of life using item banking and computer adaptive testing (Eye-tem bank) [Dr Jameel Rizwana H] l Exploring maturation of visual perception in school age children using portable devices [Dr Anuradha N/Dr Jameel Rizwana H] l Binocular vision parameters pre and post LASER vision surgery (LASIK and Epi-LASIK) [Ms. Sushmitha A D] l Changes on Ocular surface due to Anti - Glaucoma medications [Dr Rashima A] l Structural and functional analysis in different severities of glaucoma using Spectral Domain Optical Coherence Tomography and Humphrey Visual Field Analyzer [Mr. Manideepak Januwada] l Influence of astigmatism and pupil size on near visual performance such as reading speed and contrast acuity in pseudophakic eyes [Dr Rashima A] l Impact of dichoptic training on motor fusion in amblyopia [Dr Jameel Rizwana Hussaindeen] l Development of virtual reality prototype using dichoptic viewing for amblyopic training [Dr Jameel Rizwana Hussaindeen] l Vision Related Quality of Life (VRQOL) in mild and moderate traumatic brain injury (TBI) – pre and post Neuro-Optometric Vision therapy [Dr Jameel Rizwana Hussaindeen] l Neuro-optometric rehabilitation in Homonymous Hemianopia using Yoked prisms and Sanet vision integrator [Dr Jameel Rizwana Hussaindeen] l A knowledge, attitude and practice (KAP) survey of binocular vision care among eye care practitioners in India [Dr Jameel Rizwana Hussaindeen]

58 MEDICAL RESEARCH FOUNDATION l Dopamine and Melatonin in tear and serum among myopes [Ms. Azfira Hussain / Ms. Aparna G] l The combined influence of neuropathy and retinopathy in people with diabetes [Dr Rajiv Raman] l To understand the barriers and facilitators of Diabetic Retinopathy Screening & follow up: An exploratory study from India and Thailand [Dr Rajiv Raman] l Study of the real time performance of Artificial intelligence-based algorithm on images taken with a fundus camera for detecting and grading diabetic retinopathy and glaucoma [Principal Investigator : Dr. Rajiv Raman] l Role of single bolus does Dexedetomidine in providing smooth extubation and prevention of emergence delirium in paediatric ocular surgeries: A single blind randomized trial [Principal Investigator: Dr.Sonali Raman] l Comparison of Intraocular lens power calculations obtained from Argos biometer and Ultrasound biometry in paediatric cataracts [Principal Investigator : Dr. Sumita Agarkar] l Efficacy of topical Timolol for ocular pyogenic granuloma [Principal Investigator : Dr. Sonam Nisar] l Critical incidents and morbidity in paediatric patients undergoing ophthalmic surgery under general anaesthesia in a tertiary care single specialty hospital [Dr. S Lakshmi Prasanna] l Does B-scan and fundus auto fluorescence help discriminate pseudo disc edema from true disc edema [Dr. S Ambika] l Development and Validation of a Deep Learning Algorithm for Detection of Optic Disc Abnormalities [Dr. S Ambika] DNB THESIS PROJECTS : l Anatomical and Functional Outcomes of Surgery For Retinal Detachment in Closed globe injury due to Cricket Ball. [Principal Investigator : Dr. Sankadasariya Daxa Bhupatbhai] Guide: Dr. Muna Bhende l Visual outcome following intravitreal anti vegf for macular edema in different morphological pattern, based on spectral domain optical coherence tomography. [Principal Investigator : Dr. Ayush Singh] Guide: Dr. P.S. Rajesh l Structural changes [GCL+IPL and RNFL] in optical coherence tomography in relation to clinical profile and visual outcomes of optic neuritis patients in Indian population. [Principal Investigator : Dr.Mitesh Jatan Bafna] Guide: Dr. S. Ambika l Clinical spectrum of HLA-B27 associated ocular inflammation. [Principal Investigator : Dr. Ruchika Raini Lakra] Guide: Dr. Parthopratim Dutta Majumder l Comparison of risk factors, clinical features, visual outcome of central serous chorioretinopathy in women presenting to a tertiary eye care centre in the past 10 years. [Principal Investigator : Dr. Syed Moosa SM] Guide: Dr. Vikas Khetan

59 MEDICAL RESEARCH FOUNDATION

ONGOING PROJECTS l REACH- Refractive error among children [Dr T.S. Surendran] l Sankara Nethralaya Tubercular Uveitis (SANTU) Study [Dr. J Biswas] l Construction and validation of a pediatric perimeter based on eye tracking technology [Dr Ronnie George] l Normative data collection for oculomotor functions using prototype eye-tracking technology in accordance with the conventional method [Dr Ronnie George] l Protocol Number: ILJ466-P005: Post-Market Clinical Study of the Clareon® AutonoMe TM with Indian Population [Principal Investigator : Dr. Prema Padmanabhan] l Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) – A Phase 3 Study Dr. Sudha Ganesh] l The Asia Primary Tube versus Trabeculectomy (TVT) Study [Dr Ronnie George] l To study the characteristics of optic nerve head by OCT angiography after IOP reduction: A prospective study [Dr. Ronnie George / Dr. B Shantha / Dr. L Vijaya] l Clinical Imaging Study – Glaucoma [Dr Ronnie George / Dr L Vijaya / Dr B Shantha] l The Indian Childhood Glaucoma Incidence Study [Dr B Shantha] l Electrophysiological studies in eyes receiving Intravitreal Chemotherapy for Retinoblastoma [Dr Pukhraj Rishi] l Comparison of outcomes of different gas tamponade agents for macular hole surgery [Dr Pukhraj Rishi] l CRISEPTED Combined radiotherapy and intravenous steroids for the treatment of Early Progressive Thyroid Eye Disease [Dr Bipasha Mukherjee] l Early improvement in visual functions after anti-vegf in Center involving Diabetic Macular Edema [Dr Rajiv Raman] l Improving the Compliance of Patients with Diabetic Retinopathy for Regular Screening and Follow-up after Treatment of Sight Threatening Diabetic Retinopathy [Dr Rajiv Raman] l Aniso-accommodation In Children With Anisometropic Amblyopia [Dr Meenakshi S] l A Comparative study of Reading speed of anisometropic amblyopia with age matched visually normal children at a tertiary eye care center [Dr Meenakshi S] l Efficacy study of two cycloplegic regimens in eyes with dark irides [Dr Meenakshi S] l A Pilot study on Comparative analysis of MIC (Minimum Inhibitory Concentration) and MPC (Mutant Prevention Concentration) of normal human commensal conjunctival microbial flora to topical antibiotics. [Dr Meena Lakshmipathy]

60 MEDICAL RESEARCH FOUNDATION l Vision related Quality of Life in patients with low vision using the IVI -VLV questionnaire [Dr. Mona Khurana/Dr. Anuradha N] l Evaluating the effectiveness of a Dot Pattern Visual Cognition Task for the assessment of visual sequencing and visualization aptitude in elementary school children [Dr Jameel Rizwana H] l Diagnostic accuracy of indigenously developed computer based binocular vision testing and efficacy of computer based vision therapy [Dr Jameel Rizwana H] l Development and validation of a prototype to assess visual reaction time among visually normal individuals and patients with traumatic brain injury [Dr Jameel Rizwana Hussaindeen] l Pattern of Anomalous retinal correspondence (ARC) and efficacy of in-office vision therapy in improving fusional vergence amplitudes in Intermittent Divergent Squint (IDS) [Dr Jameel Rizwana Hussaindeen] l Sankara Nethralaya - Tamil Nadu Essilor Myopia (STEM) Study [Ms. G Aparna/Dr S Viswanathan/Dr Jameel Rizwana] l Evaluating the association of soft contact lens wear among contact lens wearers in their daily activities, life style, occupation, and socio economic status [Ms. Sutapa Purkait] l SNEHAM 2020 – Sankara Nethralaya Eye Hospital Anjali to Mahatma [Dr. Anuradha N] l Clinical profile and Surgical outcomes of patients with Familial exudative vitreoretinopathy (FEVR) [Principal Investigator : Dr. Ekta Rishi] l A prospective study to analyze the meibographic features in chalazion and sebaceous gland carcinoma [Dr. Sonam Nisar] l Prevalence of self-reported Falls among Visually impaired visiting Tertiary eye hospital [Principal Investigator : Ms S Ramya] l A Prospective comparative study of the Functional visual outcomes of three different Intra Ocular Lenses Bifocals, Trifocals and Extended depth of focus lenses [Principal Investigator : Dr Shikha Rajesh Bassi] l Blur threshold and blur adaptability assessment in young adult myopic patients undergoing refractive surgery [Principal Investigator : Dr R R Sudhir] l Evaluation of Macular Pigment Optical Density in Diabetic Retinopathy and correlation with its severity in Non center involving macular edema [Principal Investigator : Dr Rajiv Raman] l Protocol Title: 19140 Structured Post-marketing surveillance to collect the safety data of intravitreal aflibercept injection (IVT-AFL) in patients of wet age-related macular degeneration during real world clinical practice [Principal Investigator : Dr. Parveen Sen] l Role of Multimodal Imaging In Presumptive Tubercular Posterior Uveitis – A Prospective Study [Principal Investigator : Dr. Jyotirmay Biswas]

61 MEDICAL RESEARCH FOUNDATION l Study of nested and real-time polymerase chain reaction for mycobacterium tuberculosis DNA in the aqueous fluid of granulomatous intermediate uveitis a prospective study [Principal Investigator : Dr. Jyotirmay Biswas] l Respiratory viral Infections in Children with Febrile Neutropenia in Haemato-Oncology Unit.[Principal Investigator : Dr. H N Madhavan / Dr. Adarsh Kancharla] l BYNOCS DAT (Dichoptic Amblyopia Therapy) Game treatment for Amblyopia – A randomized controlled trial. [Principal Investigator: Dr. Jameel Rizwana Hussaindeen] l Impact of Scleral contact lens in pediatric age group. [Principal Investigator: Ms. Sona Paul] l Vault-Aberration-Vision relationship in Boston Scleral contact lens. [Principal Investigator: Ms Akshaya Balakrishnan] l Protocol Study Code: ET1901001, Evaluation of efficacy and safety of bimatoprost 0.01% (Careprost LS) preservative-free [PF] ophthalmic solution in comparison to conventional bimatoprost 0.01% (Lumigan) Ophthalmic solution for glaucoma or ocular hypertension in Indian population. [Principal Investigator: Dr. Parivadhani A] l Analysis of Retinal and Choroidal Structure using Swept Source Optical Coherence Tomography Angiography in healthy Indian eyes [Principal Investigator: Dr. Aditya Verma] l Protocol No.:010906IN, Title: Lumina: A Phase III, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 uq DE- 103 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye [Principal Investigator : Dr. J Biswas] l Protocol ID/Number: CRTH258B2302 A Two-Year, Two-Arm, Randomized, Double-Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab versus Aflibercept in Adult Patients with Visual Impairment due to Diabetic Macular Edema [Dr.Muna Bhende] l Impact of Occupational Optometry Services on Productivity and Vision Related Quality of Life of Small scale and Cottage Industry workers [Dr. Rashima A] PH.D RESEARCH PROJECT : l Low vision intervention in individuals with retinal diseases [Ms. Sarika G; Guide: Dr Rajiv Raman] DNB THESIS PROJECTS : l Clinical Profile and Short Term Outcome of Patients Sustaining Ophthalmic Injury due to Festive Bursting of Firecracker managed in the emergency department at a Tertiary Eye Care Center [Principal Investigator : Dr.Amulya Das; Guide: Dr. Pradeep Susvar] l A Retrospective Analysis of Topography of Optic Nerve Head Drusens on Spectral Domain OCT [Principal Investigator : Dr.Ramesh Pamu; Guide: Dr. Shikha Rajesh Bassi] l Natural history of keratoconus in patients of age more than 40 years. [Principal Investigator : Dr Shridhar Kulkarni; Guide: Dr. Meena Lakshmipathy]

62 MEDICAL RESEARCH FOUNDATION l Cataract Surgery in Fuchs Endothelial Corneal Dystrophy [Principal Investigator :Dr. Suhasini J; Guide: Dr. Sudhir.R. R] l Characteristics features of Macular Telangiectasia Type 2 using OCT-Angiography. [Principal Investigator : Dr Damisetti Anjali] Guide: Dr. Parveen Sen l Study of Corneal Biomechanics in corneal Dystrophies Using Corvis St [Principal Investigator : Dr.Shruthi.P.S] Guide: Dr.Niveditha Narayanan l Inflammatory Neuroretinitis: Etiology and Treatment outcome in a tertiary care uveitis center. [Principal Investigator : Dr. Pallavi Goel] Guide: Dr.Suchitra Pradeep l Comparison of intra ocular pressure reduction in primary open angle glaucoma, ocular hypertension, primary angle closure and primary angle closure glaucoma with topical anti glaucoma medications. [Principal Investigator : Dr Arun S] Guide: Dr Ronnie George l Stargardt disease – Correlation between genotype and phenotype in Indian population.[Principal Investigator – Dr Mythri K Rao] Guide : Dr Muna Bhende l A retroprospective study of Phacoemulsification with Toric intraocular lens with and without image guided marking to study the impact of image guided technology. [Principal Investigator – Dr Ashok Kumar Mandal] Guide : Dr Shikha Rajesh Bassi l Visual outcome in children with congenital rubella cataract versus non rubella cataract. [Principal Investigator : Dr. Visakh Thomas] Guide: Dr. Sumita Agarkar / Co-Guide: Dr. Mona Khurana l An observational case series on outcomes of corneal collagen cross linking in Non- Keratoconus corneal ectasia. [Principal Investigator : Dr. Sagar Udasi] Guide: Dr. Radhika Natarajan l Comparison of the visual outcome and short term complications following cataract surgery with vitreous loss between eyes with Anterior chamber intraocular lens and Posterior chamber intraocular lens. [Principal Investigator : Dr. Merin Jacob] Guide: Dr. Sripriya Krishnamoorthy l Utility of High Frequency Biomicroscopy in the Diagnosis and Treatment of Uveitis [Principal Investigator : Dr Lavanya S; Guide: Dr. Suchitra Pradeep] l Quantification of Vascular changes in Retinal Vein Occlusion using Optical Coherence Tomography Angiography (OCTA) and to find the Correlation between Vascular Indices and Cardiovascular Risk Factors [Principal Investigator : Dr Preethi B; Guide: Dr. Dhanashree Ratra] l Management Outcomes of Ophthalmic Manifestations of Carotid-cavernous fistulas in Indian Population [Principal Investigator : Dr Amol Yuvraj Ganvir; Guide: Dr. Bipasha Mukherjee / Co- Guide: Dr.Swatee V. Halbe (Apollo Speciality Hospital, Chennai)] l Outcomes of Surgical Management of Descemet’s Membrane Detachment during Cataract Surgery in a Training Centre [Principal Investigator : Dr Aman Agrawal; Guide: Dr. Sripriya Krishnamoorthy]

63 MEDICAL RESEARCH FOUNDATION l Comparative study of Surgical Outcome in Phacoemulsification with Posterior Polar Cataract in 2 ERAS 10 years apart in a group of surgeons [Principal Investigator : Dr. Adheela Abdulla; Guide: Dr. Shikha Bassi] l Clinical Profile, Diagnosis and Management of Familial Exudative Vitreoretinopathy in the Indian Population [Principal Investigator : Dr Thatigotla Naga Amulya; Guide: Dr. Girish S Rao] l Correlation of Digital Slit Lamp Photography with Clinical features in Infective Keratitis. [Principal Investigator : Dr Doshi Aashna Premal; Guide: Dr. N Radhika] l Treatment Outcomes Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Patients with Myopic Choroidal Neovascularization [Principal Investigator : Dr Ganesh V; Guide: Dr Vikas Khetan] l Analysis of Retinal Changes with Optical Coherence Tomography Angiography in Patients having Diabetic Macular Edema with Proliferative Diabetic Retinopathy as Compared with those having Diabetic Macular Edema without Proliferative Diabetic Retinopathy before and after Anti- Vascular Endothelial Growth Factor Therapy [Principal Investigator : Dr Nila D Dev; Guide: Dr. Aditya Verma] l Exploring, Developing and validating a predictive model for OCT markers of Inflammation vs Angiogenesis in Macular Edema [Principal Investigator : Dr Meenakshi Mahesh; Guide: Dr. Rajiv Raman] l Impact of Optic Disc size on Retinal Nerve Fiber Thickness in Normal Eyes and Glaucomatous Eyes [Principal Investigator : Dr Sitesh Vats; Guide: Dr. Ronnie Jacob George] l Study of risk factors for corneal decompensation following Cataract Surgery in Patients of Fuchs Endothelial Corneal Dystrophy [Principal Investigator : Dr Saurabh Gupta; Guide: Dr. R R Sudhir] l A Clinical and Microbiological Study of Panophthalmitis Cases managed in a Tertiary Care Centre [Principal Investigator : Dr Mehta Parth Kirit; Guide: Dr. Chetan Rao] l Hospital Anxiety and Depression Scale Assessment of patients with intraocular tumor before and after therapy [Principal Investigator : Dr Khandharwar Mahavir; Guide: Dr. Pukhraj Rishi] l A Study of swept source OCT and OCT -Angiography features of Pathological Myopia [Principal Investigator : Dr Amber Dubey; Guide: Dr. Pradeep S] l Functional Outcome of Descemet Membrane Endothelial Keratoplasty in Corneal Endothelial Disorders [Principal Investigator : Dr Sneha Bhopatkar; Guide: Dr. Bhaskar Srinivasan] l Comparison of Accuracy of 8 Intra Ocular Lens Power Calculation Formulas in patients Undergoing Cataract Surgery [Principal Investigator : Dr. Catharine Joby; Guide: Dr.Vineet Ratra] l Visual Outcome Post Cataract Surgery in Patients with an Axial Length more than 26mm [Principal Investigator : Dr. Radhika Sriram; Guide: Dr. P S Rajesh] l Visual Outcomes and Morbidity in Pediatric Uveitis Patients in Tertiary Care Centre [Principal Investigator : Dr Sivakoti Rama Naga Prasanna; Guide: Dr. Parthopratim Dutta Majumder]

64 MEDICAL RESEARCH FOUNDATION l Outcomes of therapeutic penetrating keratoplasty in fungal keratitis [Principal Investigator : Dr. Marella Alekya; Guide: Dr. Mamta Agarwal] RA FELLOWSHIP : l Cellular and molecular study on the prevalence of viral induced pathogenesis of pterygia in India and evaluation of the role of adjuvants in anti fibrogenic activity Dr. M K Janani [Guide: Dr. H. N. Mathavan] Ph.D : l A prospective study to analyze the impact regarding awareness about exercise measures and adoption of better postures pertaining to musculo-skeletal disorders (MSD) among post- graduates in the ophthalmology stream. Dr. Vishnu Vahan Prasan [Guide: Dr. R R Sudhir] M.OPTOMETRY PROJECT : l The effect of therapeutic intervention on the ocular lipid layer in Stevens Johnson Syndrome [Mr Soumen Sadhu Guide: Dr Bhaskar Srinivasan/ Dr Geetha Iyer] l Nagel Anamoloscope, Its normative database, test retest variability and utility in optic nerve head pathologies. [Ms. Nabanita Ghosh Guide: Dr. Rashima A] l Establishment of clinical profile of pseudoexfoliation in a hospital based setup and comparison of the structural changes between pseudoexfoliation and pseudoexfoliation glaucoma [Mr Sourabh Jandyal [Guide: Dr. Rashima A] l Visual functions following successful anatomical reattachment in macula off Retinal detachment [Ms. Jebacynthia [Guide: Dr Muna Bhende/Dr. Jameel Rizwana Hussaindeen] l Assessment of Accommodative parameters and pupillary responses in Duane’s Retraction Syndrome (DRS) [Mr. Bongoni Viswanath [Guide: Dr. Jameel Rizwana Hussaindeen] l Analysis of change in visual function in individuals with Low vision using Samsung Gear – Pilot Study Ms. Gnanapoonkodi B [Supervisor: Dr Rajiv Raman]

65 MEDICAL RESEARCH FOUNDATION

PARTICIPATION IN CONFERENCES l Dr. Prema Padmanabhan and Dr .Vikas Khetan, participated in the ARVO Conference from 25th April 2019 to 04th May 2019. They made a Poster Presentations on “Spectrum of Binocular Vision Function in Keratoconus Patients” and “Aqueous flare in uveitis: Measurements with an enhanced spot fluorometer”. l Dr. Prema Padmanabhan participated in the CME in Narayana Nethralaya at Bangalore from 18th to 19th May 2019. l Dr. Vijaya L attended the CME at Ludhiana from 27th to 29th April 2019. l Dr. Pramod S Bhende participated in the Sankara Nethralaya Kolkata CME on 20th to 21st April 2019. l Dr. Jaichandran V V attended the Vision 2020 Annual Conference at Aravind Eye Hospital on 08th June 2019. He gave a presentation on “Minimizing and Managing Systemic Emergencies occurring in an Eye Hospital”. l Dr. Jaichandran V V participated in the 67th Annual conference of Indian Society of Anaesthesiologists (IAS) at Bangalore from 26th to 29th 2019. l Dr. Pramod S Bhende participated in the RETNET conference at Bangalore from 08th to 09th June 2019. l Dr. Pramod S Bhende participated in the ROP conference at Hyderabad from 12th to 14th June 2019. l Dr. Pramod S Bhende, Dr. Parveen Sen and Dr. Pukhraj Rishi, attended the 4th Annual conference of Indian Retinopathy of Prematurity Society at Hotel J W Marriott & Auditorium, Advanced Eye Centre, PGIMER, Chandigarh from 21st to 22nd June 2019. Dr. Pramod S Bhende presented on “Management of stage 4 ROP”, Dr.Parveen Sen on “Is it ROP or FEVR ?”, “Early surgery for APROP” and Dr. Pukhraj Rishi on “Case presentation - Stretch retinal hole in post-vitrectomised eye for stage IV-A ROP”. l Dr. Pradeep S attended the Retnet conference at Bangalore from 07th to 08th June 2019. l Dr. Rajiv Raman participated in the Retina Beyond meeting at Taiwan from 21st to 22nd June 2019. l Dr. Sudhir R R attended Vision 2020 Annual conference at Arvind Eye Hospital on 08th June 2019. l Dr. Jaichandran V V Participated in the State conference ISACON at Chennai, Tamilnadu from 27th to 28th July 2019. He gave a presentation on “Ophthalmic Blocks”. l Dr. P. Durgadevi attended “Hands on workshop on microbiome screening and pathogen identification using Nanopore sequencing technology” conducted by Genotypic technology at Bangalore on 13th July 2019. l Dr. L. Dhanurekha, Dr. P. Durgadevi, attended the IERG conference held on 27th and 28th July 2019 at Chennai. Dr. L. Dhanurekha has presented poster entitled “Application of Novel duplex PCR for the rapid detection of Pythium insidiosum in corneal specimens of ocular pythiosis patients” and Dr. P. Durgadevi on “Reverse Transcriptase PCR (RT-PCR) for detection of Toll like Receptors in infective fungal keratitis samples”.

66 MEDICAL RESEARCH FOUNDATION l Dr. Mona Khuran, Dr. K. Lily Therese, Dr. A. R. Anand & Dr. Reni Philip attended the Asia ARVO IERG held at Ambassador Pallava from 27th to 28th July 2019. l Dr. Muna Bhende and Dr. Parveen sen attended the Retinal Imaging Congree 2019 at Chaithanya Eye Hospital at Thiruvananthapuram from 18th to 20th July 2019. l Dr. Jyotirmay Biswas, Dr. Smita Praveen, Dr. Bhaskar Srinivasan, Dr. Meena Lakshmipathy, Dr Suganeswari, Dr. Kavita Kalaivani, Dr Rajiv Raman , Dr. Meenakshi Swaminathan, Dr. Parivadhini.A, Dr. Mona Khurana, Dr. Rathini Lilian David, Dr. Radhika N, Dr. Suchitra pradeep Participated in the 67th Annual Conference of Tamil Nadu Ophthalmic Association at Salem from 09th to 11th August 2019. Dr. Jyotirmay Biswas presented the topic “A case of Vogt Koyanagi Harada’s disease”, Dr. Bhaskar Srinivasan “Surgical management of Dry Eye”, Dr. Meena Lakshmipathy “Acanthamoeba keratitis”, Dr Suganeswari “Principles and goals of surgery in vitrectomy for rhegmatogenous RD” , “The Bodhi Tree Session B-Scan”, Dr. Kavita Kalaivani “Cortical visual impairment- the Ophthalmologist's role in early detection and management”, Dr Rajiv Raman “Artificial Intelligence and DR screening – where are we today?”, “Oblique muscle surgeries”, Dr. Parivadhini.A “Tubes & Shunts”, “A focus on diode cyclophotocoagulation and micro pulse diode”, Dr.Rathini Lilian David “Can SLT be used as a primary treatment modality?”, “A critical review of the LiGHT trial.2”, Dr. Mona Khurana “Endoscopic cyclophotocoagulation: When and How to perform”, Dr.Trupti Sudhir Patil “Practical and evidence based use of Lasers in angle closure disease and plateau iris” and Dr. Radhika N presented on “Symposium Keratitis – Assorted”. l Dr. Muna Bhende, Dr. Parveen Sen and Dr .Pramod S Bhende participated in the Retina forum meeting at Delhi from 24th to 25th August 2019. l Dr. Jaichandran V V participated in the 05th OFISACON conference at Bengaluru- from 06th to 07th September 2019. He made a presentation “Regional anaesthesia for Open Globe Injury”. l Dr. Kannan R participated in the OFISA conference at Bangalore on 07th to 8th September 2019. He gave a presentation on “Mandatory Documentation: NABH Stranded Perspectives”. l Dr. Prema Padmanabhan, Dr. Rama Rajagopal, Dr. Radhika N and Dr. Sudhir R R participated in the 10th Eucornea Congress 2019 from 11th to 19th September 2019. Topics “Unusual corneal flattening following collagen crosslinking for keratoconus: overtreatment or over-response?”, “Fate of the untreated fellow eye of patients with bilateral keratoconus with unilateral collagen crosslinking”, “Clinical and microbiological profile of eyes collected from multiorgan donors in a tertiary care centre - Can they be used?”, “Visual Outcomes Of Penetrating Keratoplasty In Eyes With Iridocorneal Endothelial Syndrome(Ice)” were presented by the team. l Dr. Manonmani B participated in the Ophthalmic Anaesthesia Society annual conference at Chicago from 11th to 20th September 2019. She gave a poster presentation on “Hyaluranidase Hypersensitivity after peribulbar Block Hard to diagnose - is it?”. l Dr Sujatha R participated in the 33rd Ophthalmic Anaesthesia Society Conference at Chicago from 11th to 15th September2019. She gave a talk on “Anaesthesia for Neonates”.

67 MEDICAL RESEARCH FOUNDATION l Dr. Shantha B, Dr. Sripriya Krishnamurthy, Dr. Vijaya L, Dr Ronnie Jacob George and Dr. Parivadhini A, attended the Glaucoma society of India conference at Lucknow from 20th to 22nd September 2019. Dr. Parivadhini A presented on topic "Angle closure Disease - Medical management of Glaucoma". l Dr Pramod S Bhende, Dr. Muna Bhende and Dr. Vinata Muralidharan participated in the EuRetina conference at Paris 2019 from 05th to 8th September 2019. Dr. Promod Bhende gave a Presentation on “Pediatric retinal detachments - No child’s play” , “A lens, an IOL and a giant retinal tear (GRT) – The result of a fishing expedition” and Dr. Muna Bhende presented on “To study the surgical and functional outcome of vitrectomy for retinal detachment (RD) secondary to cytomegalovirus retinitis (CMVR) in patients with acquired immune deficiency syndrome (AIDS)”. l Dr.Vikas Khetan attended the OPAI meeting at Guwahati from 05th to 07th September 2019. l Dr. Niveditha Narayanan, participated in the Women Ophthalmologists Society (WOS 2019) at Hotel Sheraton Grand, Bengaluru, India from September 08th to 10th 2019. She made a presentation on “Aberrations In Pellucid Marginal Degeneration (PMD)”. l Dr Meena Lakshmipathy participated in the pediatric conference at LVPEI, Hyderabad, Telangana from 08th to 10th November 2019. She made a presentation on “Advanced Paediatric Cornea and Neurotisation Workship”. l Dr. Sudha K Ganesh , Dr. Amala Elizabeth , Dr. Sudharshan S, Dr. Parthapratim Dutta Majumder attended the USI meeting at Bangalore from 19th to 22nd September 2019. l Dr. Parthapratim Dutta Majumder, Dr. Sharanya Sarah Abraham, attended the All Gujarat Ophthalmological Conference Ahmedabad from 27th to 28th September 2019. l Dr. Anuradha N participated in the American Academy of Optometry Conference at Orlando, Florida from 21st to 31st October 2019. She gave a talk on “Role of school eye screening in promoting gender equity". l Dr.Rama Rajagopal, Dr. Radhika N, participated in the 32nd APACRS Annual meeting at Kyoto from 03rd to 05th October 2019. Dr. Rama Rajagopal presented on “Deep Anterior Lamellar keratoplasty (DALK) in corneal scars and dystrophies” and Dr. Radhika N presented a paper titled “Outcome of Cornela perforation”, Video Presentation titled in the mind’s eye”. l Dr. Sripriya Krishnamurthy, Dr. Muna Bhende, Dr. Pramod S Bhende and Dr. Girish S Rao attended the MOSCON Conference at Mumbai from 18th to 19th October 2019. Dr. Sripriya Krishnamurthy presented on “phacoemulsification basics” and “glaucoma in corneal diseases”. l Dr. Radhika N and Dr. Niveditha Narayanan Participated in the Bug Buster at Corneal Infection workshop 2019 at Hyderabad on 19th October 2019. Dr. Niveditha Narayanan presented the topic “Pseudomonas Keratitis Our Roles and Responsibilities” and Dr. Radhika N presented on “Infectious Keratitis -Protocol for Bacterial Keratitis”. l Dr. A R Anand and Dr. P. Durgadevi, participated in the “International Science Symposium on HIV& Infectious Diseases at Sri Ramachandra Institute of Higher education and research (SRIHER) from 12th to 14th October 2019.

68 MEDICAL RESEARCH FOUNDATION l Dr. A. R. Anand attended SIRCON meeting on 12th October and 13th October 2019. He delivered a talk entitled “PCR in uveitis” at the Pre-conference CME programme on 12th October 2019. l Dr. L. Dhanurekha, Ms. Harinee R participated in the SIRCON conference held on 12th and 13th October 2019 at Chennai. Ms. Harinee R has presented poster entitled “Curcumin alleviates LPS- induced pro-inflammatory cytokine expression in hepatic stellate cells” and Dr. L. Dhanurekha presented Poster entitled “Molecular detection of Mycobacterium tuberculosis genome from suspected Ocular Tuberculosis patients- A four year retrospective study from a tertiary eye care hospital”. l Dr. A. R. Anand attended CME program entitled “Nephelometry & Its Clinical Applications” on 16th October 2019 at Benzzpark T.Nagar. l Dr. Pramod S Bhende participated in the CME on Surgical Retina on 12th October 2019. l Dr. Sudhir R R, attended 32nd APACRS Annual Meeting at Kyoto from 03th to 05th October 2019. He made a presentation on “Long term outcomes of Keratoconus patients after Topography guided custom ablation with collagen cross linking (TCAT + CXL)”. l Iyer Geetha Krishnan and Dr. Bhaskar Srinivasan attended the American Academy of Ophthalmology in SFO, from 12th to 15th October 2019. Dr. Bhaskar presented the Breakfast Kpro Meeting Topic “K-pro in oil filled eyes”, he is the co-Instructor for the “Pediatric Corneal Conditions- IC”, Topic “Pediatrics DALK”, he is the Wet lab Instructor in OSD Skill Transfer Wetlab. Dr. Iyer Geetha Krishnan presented the Breakfast Kpro Meeting Topic “Carrier graft melts and their management”, E-Poster titled “Kpro-The Journey after”, Skill Transfer Course “KPro for the very dry patient”, IC course “Pediatric Corneal Conditions”, topic “Paediatric OSD”, “AMT vs. Alloslet in severe grade ocular chemical injuries”, and E-Poster titled “Long term Outcomes of MMG for SJS”. l Dr. Girish Rao attended the 43rd Annual Conference of Madhya Pradesh Atate Ophthalmic Society at Madhya Pradesh from 18th to 20th October 2019. l Dr. Arshee S Ahmed participated in the CME Programme on 12th October 2019. l Dr. Ronnie Jacob George attended the Kerala Society of Ophthalmic Surgeons:[KSOS] at Kerala from 21st to 23rd November 2019. He gave presentations on “Clues to a Neurological component on Perimetry in a glaucoma patient, Structure- function correlation in glaucoma, High frequency focused Ultrasound endocyclophotocoagulation, Surface tension and thin fluids (gas and hydro techniques), Aurolab Aqeous Drianage Implant Late Bleb associated complications and management.” l Dr. Meena Lakshmipathy, participated in the CME on Infectious Keratitis at Aravind Eye Hospital, on 3rd November 2019. She made a presentation on “Debate on Bacterial Keratitis – Clinical Vs Microbiological Post CXL Infections”. l Dr. Niveditha Narayanan participated in the EBAI conference at Hyderabad from 09th to 10th September 2019. She made a presentation on “Optical Grade Donor Corneas for therapeutic penetrating Keratoplasties (PK)”.

69 MEDICAL RESEARCH FOUNDATION l Dr. Muna Bhende attended the LVPEI Oration at Hyderabad on 16th November 2019. l Dr. Amala Elizabeth George, Dr. Sudharshan S and Dr. Mamta Agarwal participated in the International ocular Inflammation Society (IOIS) at Taiwan from 12th to 16th November 2019. l Dr. Sudharshan S participated in the KOSON conference at Belagavi from 08th to11th November 2019. l Dr. Sudhir R R attended the EMR Implementation at Chaitanya Eye Hospital from 13th to 14th November 2019. l Dr. Shobha Ravishankar attended the conference on First European Society of Ophthalmic Anaesthesia held in Engelberg, Switzerland from 03rd to 08th December 2019. She gave an invited talk titled “Anaesthetic management of a child with Tessiers type 4 for ophthalmic surgery”. l Dr. Jaichandran V V attended as faculty at European Society of Ophthalmic Anaesthesia congress at Engelberg, Switzerland from 05th to 06th December 2019. He gave a talk on “Anaesthesia for MOOKP” and participated in panel discussion titled “Teaching Ophthalmic Anaesthesia to the New trainees”. He also conducted Sub-Tenon’s block hands-on practice session using simulator module. l Dr Sujatha V attended the ESOA a Switzerland from 04th to 07th December 2019. l Dr .Meena Lakshmipathy attended the Keracon Conference at Kumarakom, Kerala from 13th to 14th December 2019. She made a presentation on “Viral Keratitis mimics”. l Dr. Sudhir R R, Dr. Iyer Geetha Krishnan, Dr. Bhaskar Srinivasan and Dr.Mamta Agarwal participated in the keracon conference kumarakom at kerala from 13th to 14th December 2019. Dr.Sudhir R R , Dr. Iyer Geetha Krishnan “Keratoglobus in a 9 year old managed with limbal sparing LK” , “AlloSLET Vs MMG in immune disorders” and “Various Kpros the Journey and Challenges”, Dr. Mamta Agarwal presented on “Infectious Scleritis – Clinical features, diagnosis and treatment outcome in Indian population” , “Acanthamoeba keratitis – Epidemiology, clinical features and visual outcome” and Dr. Bhaskar Srinivasan “AMT vs AlloSLET in acute chemical injuries” and acted as moderator for Kpro session. l Dr. L. Dhanurekha participated in the 74th National conference of Tuberculosis and chest disease at Chennai from 21st to 22nd December 2019.She made a poster presentation on “Genotypic identification of Non Tuberculous Mycobacteria from culture proven isolates- A 7 years’ retrospective study from a Referral laboratory. l Dr. Pramod Bhende Dr. Muna Bhende, Dr. Ekta Rishi Dr. Rajiv Raman, Dr. Jayaprakash V and Dr. Vikas Khetan, attended the 28th Annual Conference of Vitreo Retinal Society, India (VRSI) at Lucknow from 05th to 08th December 2019. Dr. Muna Bhende presented on “RAP – Clinical Profile and Management” , Dr. Ekta Rishi on “Drusen ooze presenting with sub retinal fluid in non neo vascular age related macular degeneration, Analysis of adverse reactions in subjects undergoing fluorescein or indocyanine green angiography: Six years study , Salvaging an eye with endophthalmitis and permanent keratoprosthesis”, Dr. Pramod Bhende on “Buckling in Challenging Situations – II”, “Vitrectomy for Advanced ROP (Stage 4 & 5) Detachments”, Dr. Rajiv Raman on “Artificial Intelligence: Dr and Beyond”, Dr. Jayaprakash V on “Acute Macular Neuroretinopathy AMN)” Dr. Vikas Khetan on “Management of Ocular Melanomas”, and Dr. Pradeep Susvar presented on “Macular Buckling”.

70 MEDICAL RESEARCH FOUNDATION l Dr. Mamta Agarwal attended the KERACON 2019 at Kerala from 12th to 14th December 2019. l Dr. Ronnie Jacob George attended the ICON 2020 at Vellore from 30th to 31st January 2020. He gave a presentation on “Screening Strategies for Glaucoma“. l Dr. Sujatha V K Participated in the Santen Vision Summit 2020 at Bangkok, from 09th to 11th January 2020. She gave a presentation on “Outcomes of direct cyclopexy for repair of cyclodialysis clefts”. l Dr.Jaichandran V V participated in the 5th World Congress of Ophthalmic Anaesthesia (WCOA), Jakarta, Indonesia from 7th to 8th February 2020 from 06th to 08th February 2020. He gave a talk on “Retained Visual sensations during Eye Surgery”. l Dr. Radhika N participated in the AIOS Conference at 13th to 16th February 2020 and has been the IC Chief Instructor for the course titled “Customising Keratoplasty: Penetrating Keratoplasty in the Era of Layer Transplants” , “Aphakia Management in A Grafted Eye”. l Dr. Muna Bhende, Dr. Rajesh P S, Dr. Ronnie Jacob George, Dr. Mona Khurana, Dr. Trupti Sudhir Patil, Dr. Sujatha V K, Dr. Smita Panda, Dr. Parveen Sen, Dr. Chetan Rao , Dr .Rajiv Raman, Dr Dhanashree Ratra, Dr. Jyotirmay Biswas, Dr. Niveditha Narayanan and Dr. Bhaskar Srinivasan participated in the All India Ophthalmic Society (AIOS) at Gurugram from 13th to 16th February 2020. Dr Muna Bhende presented the topic “MIRNA and LNCRNA Signature Discovery as Potential Biomarkers in Polypoidal Choroidal Vasculopathy”, “The Glaucoma Suspect Puzzle: A Practical Algorithm” and Dr. Niveditha Narayanan on “Clinical outcomes of DSAEK by TACO technique”. Dr.Rajesh P S “FFA and Ultrasound”. l Dr. Meena Lakshmipathy participated in the Sparck conference at Nagpur on 29th February 2020. l Dr. Radhika N, Dr. Sudhir R R, Dr. Bhaskar Srinivasan, participated in the 34th Asia-Pacific Academy of Ophthalmology Congress in Bangkok from 06th to 09th March 2019. Dr. Radhika N presented on “Corneal Perforations Secondary to Infective Etiology - What Is The Outcome?”, “Scleral and Rigid gas permeable contact lenses in the management of keratoconus - How Do They Compare?", Dr. R. R. Sudhir on “How good is American Society of Cataract and Refractive Surgery (ASCRS) Online Calculator in Predicting Cataract Surgery Outcomes in Patients Post Lasik and Post Radial Keratotomy?”, “ Performance of an Ocularfluorometer Equipped with a Lock-In Amplifier for Measurement of Aqueous Flare: Data from Uveitis and Post-Cataract Patients” and Dr. Bhaskar Srinivasan presented on “Clinical Features and Cytokine Profile in Patient’s with Recalcitrant SJS (Free Paper)".

71